US20020002391A1 - Method and apparatus for therapeutic laser treatment - Google Patents
Method and apparatus for therapeutic laser treatment Download PDFInfo
- Publication number
- US20020002391A1 US20020002391A1 US09/847,235 US84723501A US2002002391A1 US 20020002391 A1 US20020002391 A1 US 20020002391A1 US 84723501 A US84723501 A US 84723501A US 2002002391 A1 US2002002391 A1 US 2002002391A1
- Authority
- US
- United States
- Prior art keywords
- radiation
- approximately
- treatment
- tissue
- radiation source
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 48
- 230000001225 therapeutic effect Effects 0.000 title claims abstract description 36
- 238000013532 laser treatment Methods 0.000 title claims description 10
- 230000005855 radiation Effects 0.000 claims abstract description 270
- 238000011282 treatment Methods 0.000 claims abstract description 132
- 239000000835 fiber Substances 0.000 claims abstract description 38
- 239000013307 optical fiber Substances 0.000 claims description 8
- 241000124008 Mammalia Species 0.000 abstract description 3
- 230000005670 electromagnetic radiation Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 33
- 238000002647 laser therapy Methods 0.000 description 10
- 239000004065 semiconductor Substances 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 6
- 206010003246 arthritis Diseases 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 230000000994 depressogenic effect Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 238000013403 standard screening design Methods 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000001427 coherent effect Effects 0.000 description 3
- 230000009977 dual effect Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 230000002407 ATP formation Effects 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 206010006811 Bursitis Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023230 Joint stiffness Diseases 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 208000023178 Musculoskeletal disease Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000021945 Tendon injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- MDPILPRLPQYEEN-UHFFFAOYSA-N aluminium arsenide Chemical compound [As]#[Al] MDPILPRLPQYEEN-UHFFFAOYSA-N 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- -1 for example Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000010197 meta-analysis Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002406 microsurgery Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 230000007383 nerve stimulation Effects 0.000 description 1
- 239000000712 neurohormone Substances 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 102000008434 neuropeptide hormone activity proteins Human genes 0.000 description 1
- 108040002669 neuropeptide hormone activity proteins Proteins 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000886 photobiology Effects 0.000 description 1
- 230000000649 photocoagulation Effects 0.000 description 1
- 238000001126 phototherapy Methods 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0616—Skin treatment other than tanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0644—Handheld applicators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/067—Radiation therapy using light using laser light
Definitions
- the invention is directed to an apparatus and a method for applying laser beam energy in the treatment of medical conditions. More specifically, the present invention is concerned with an apparatus that uses wands emitting visible laser beam energy and invisible infrared laser beam energy.
- the method of the invention comprises positioning the wands over the patient in a manner such that the infrared radiation from the wands intersects within the body of the animal that is subjected to therapy.
- Medical and dental applications for low level laser beam energy of varying wave lengths also include pain control, nerve stimulation, reduction of edema, reduction of inflammation, arthritis, muscle and tendon injuries, and stimulation of the body's neurohormone system.
- Other applications have demonstrated increased activity in cells specifically connected with the immune system and antigen response.
- Conventional low power (less than 100 milliwatts) laser therapeutic devices generally comprise a hand held probe with a single laser beam source, or a large stationary table console with attached probes powered by a conventional fixed power supply.
- a common laser beam source is the laser diode.
- Laser diodes are readily available in varying power and wavelength combinations. Large probes containing multiple laser diodes are also known.
- Isakov et al. in U.S. Pat. No. 4,069,823, disclose an apparatus for laser therapy including one or several lasers, a light guide and a focusing barrel wherein there are at least two platforms for transverse and longitudinal travel so that tissue can be dissected.
- the patent also discloses the use of a visible light beam that coincides with the laser beam thus allowing the surgeon to accurately aim the invisible laser beam to the required point.
- CO 2 lasers with wavelengths in the area of 1060 nm are employed. This patent also suggests laser beam densities of up to 10 5 watts per square centimeter.
- Kanazawa et al. disclose in U.S. Pat. No. 4,640,283, a method of curing athlete's foot by laser beam irradiation.
- This patent discloses the use of a laser such as a CO 2 laser or a YAG laser that emits a laser beam in the infrared region having a wavelength of 700 nm or more.
- Energy levels are disclosed as two joules per centimeter squared or more for a period of ten milliseconds or less.
- This patent does not suggest or disclose the use of an apparatus including at least two wands for the laser therapy of medical conditions such as arthritis and bursitis.
- Muchel in U.S. Pat. No. 4,699,839 discloses an optical system for therapeutic use of laser light.
- the Muchel instrument provides for combined observation of and laser treatment of a portion of a human body, such as an eye.
- This patent discloses the construction of main objective lenses within certain parameters adapted to combine laser therapy radiation from multiple sources.
- One source emits radiation having a wavelength of, for example, 1064 nm.
- a second source emits laser target light radiation having a wavelength of 633 nm.
- a third source emits an observation light in the visible spectrum range of from 480 nnl to 644 nm.
- U.S. Pat. No. 4,671,285 to Walker discloses the treatment of human neurological problems by laser photo simulation.
- This patent relates to a method of treating nerve damage in humans by applying an essentially monochromic light to the skin area adjacent to the damaged nerve region.
- the inventor describes the use of a helium neon laser (632.5 nm, 1 milliwatt, and 20 hertz) with a fiber optic probe, which is held against the skin of the patient.
- the inventor also states that irradiation with infrared lasers (1090 nm) had no effect. This reference actually teaches away from the present invention.
- Liss et al. teach in U.S. Pat. No. 4,724,835 a therapeutic laser device using a pulsed laser wave.
- the Liss et al. device uses a gallium aluminum arsenide diode as the source of laser energy that is in the infrared band (wavelength of approximately 900 nm).
- U.S. Pat. No. 4,396,285 to Presta et al. relates to a laser system for medical applications that has at least two lasers and a movable concave reflector.
- One of the beams, an imaging beam is aligned to impinge on the reflector, to reflect therefrom and to impinge on a biological specimen.
- the reflector is moved until the beam is aligned to impinge on the desired location of the specimens.
- the second beam is also aligned to impinge on the reflector to reflect therefrom and to impinge on the same desired position as that impinged upon by the first beam.
- the second laser is typically disclosed to be a CO 2 laser that generates the second beam having a wavelength of 10.6 microns.
- the Presta system is disclosed as being useful for microsurgery.
- This reference does not disclose a laser therapy apparatus wherein the therapeutic radiation and the targeting radiation are merged so as to be coincidental on the surface of the patient's skin and at least two wands for positioning the intersection of the beams within the body of the patient.
- U.S. Pat. No. 4,930,504 to Diamantopoulos et al. relates to a device for biostimulation of tissue which comprises an array of monochromic radiation sources of a plurality of wavelengths, preferably at least three different wavelengths.
- this patent discloses the treatment of patients with a multi-diode biostimulation device having emitted frequencies of 660 nm, 820 nm, 880 nm, and 950 nm.
- the power levels disclosed are between 5 milliwatts and 500 milliwatts.
- This patent also discloses obtaining the radiation from a plurality of sources whose outputs are combined to a single emergence region with flexible optic fibers.
- U.S. Pat. No. 5,147,349 to Johnson et al. discloses a diode laser device for photocoagulation of the retina.
- the inventors disclose that the elliptical laser beam is shaped into a circle by an optical system before it is coupled to the fiber optic cable of the delivery system.
- the non-coherent light is generated by an array of conventional light emitting diodes with wavelengths in the red or infrared bandwidth. Infrared frequencies in the area of 940 nm, more particularly 880 nm are disclosed.
- U.S. Pat. No. 5,409,482 to Diamantopoulos discloses a probe for biomodulation.
- the probe includes a semiconductor laser and a drive circuit adapted to operate the laser to emit pulses and bursts.
- the system according to this patent has a laser beam wavelength of 850 nm and a frequency of 352 ⁇ 103 GHz pulsed at 300,000 and additionally modulated at a frequency of from 1 Hz to 2 GHz
- Bellinger in U.S. Pat. No. 5,445,146 describes a laser system for the stimulation of biological tissue that emits radiation with a power of from 100 to 800 milliwatts in either a pulsed or continuous mode.
- the laser disclosed has a fundamental wavelength of 1064 nm and delivers an energy density of from about one joule per square centimeter to about 15 joules per square centimeter.
- Smith in U.S. Pat. No. 5,464,436 discloses a laser therapy apparatus having a wavelength in the range of 800 to 870 nm and more preferably about 830 nm.
- the laser light is delivered to the afflicted area at a level of about one joule per square centimeter. Smith also suggests that the afflicted area be monitored after the treatment cycle and that treatment steps be repeated to the afflicted area.
- U.S. Pat. No. 5,527,350 to Grove et al. discloses a method for treating psoriasis through the use of pulsed infrared laser irradiation.
- An infrared diode laser is used having a wavelength of 800 nm and a pulse duration in the millisecond range. Energy levels of 5.0 to 50 joules per square centimeter are disclosed.
- U.S. Pat. No. 5,616,140 to Prescott discloses a portable laser bandage having one or many lasers or hyper-red light emitting diodes embedded in the bandage.
- the hyper-red light emitting diodes are disclosed as having wavelengths of about 670 nm.
- PCT Application PCT/US93/04123 discloses a low level laser for soft tissue treatment wherein the laser is a Nd:YAG laser, which produces 100 to 800 milliwatts in a pulsed or continuous mode.
- the therapeutic laser apparatus has at least two independent fiber optic laser outputs terminating with wands that have apertures with variable foci.
- the inventive apparatus also has a main function block wherein the therapeutic infrared radiation is combined with visible laser light and fed into fiber optic cables via couplers. The fiber optic cables transmit the radiation to the wands.
- the main function block also contains at least two infrared diode lasers and at least two red diode lasers.
- the amount of energy applied by each wand can range from about 200 to about 2,000 milliwatts.
- the wands are held in each hand of the caregiver at an angle of about 45° relative to the plane of the patient or biological tissue undergoing treatment.
- the wands are slowly moved in small circular motions favoring positions that allow the beams of laser radiation to intersect in the body at the site of the malady.
- the apparatus according to the invention can be effectively used to treat joints affected by arthritis and sore muscles. Patients with advanced forms of degenerative arthritis have experienced pain relief and, over time, revitalization of joints previously affected by the disease.
- two infrared diode lasers and two red diode lasers are preferably coupled so that these two frequencies are transmitted to the wands via the fiber optic cable.
- the combined infrared laser radiation and the visible laser light exit the treatment aperture in the wand coincident and therefore provide an excellent aiming mechanism to the caregiver or patient.
- the diameter of the fibers used in the apparatus according to the invention may vary over a wide range. However, the diameter is preferably between approximately 400 microns and approximately 800 microns, and more preferably approximately 600 microns, and even more preferably approximately 400 microns.
- the preferred wavelength of the infrared lasers is between approximately 900 nm and approximately 1100 nm with the best results being obtained with a wavelength of about 980 nm.
- the low power visible aiming laser component is typically a red diode laser having a wavelength of between about 400 nm and about 700 nm, and more preferably between about 635 nm and about 640 nm. The wavelength of approximately 635-640 nm is preferred because of its high visibility and minimized effect on the human eye.
- the power output per wand can range from about 0.0001 milliwatts watts to about 2.0 watts.
- a device for photobiostimulation of biological tissue that includes:
- a second plurality of aiming radiation sources each emitting a respective second radiation beam having a wavelength of between approximately 400 nm and approximately 700 nm; wherein at least one first beam and one second beam concurrently pass through at least one of a plurality of fiber optic cables;
- the invention also contemplates and discloses a biostimulation device that includes a laser apparatus including a plurality of treatment laser wands each connected to a laser radiation source adapted to emit radiation having a power of between about zero and approximately 2.0 watts, an energy of between about 1 joules and about 99 joules, and a wavelength of between approximately 900 nm and 1100 nm; and wherein the laser wands are arranged in an operative position to emit the radiation incident to a region of biological tissue for a therapeutically effective length of time between approximately one and approximately sixty minutes.
- a system for photobiostimulation of biological tissue includes a controller unit including a power supply and a control panel having operator input devices and output devices;
- the controller unit also including a first plurality of treatment radiation sources each emitting a respective first radiation beam having a wavelength of between approximately 900 nm and approximately 1100 nm;
- the controller unit also including a second plurality of aiming radiation sources each emitting a respective second radiation beam having a wavelength of between approximately 400 nm and approximately 700 nm; wherein at least one first radiation beam and one second radiation beam concurrently pass through at least one of a plurality of fiber optic cables; and
- At least two wands each connected to a different one of the plurality of fiber optic cables, the wands including a collimator configured to establish the shape of the emanating coincident radiation beams; wherein the wands are arranged in an operative position about the tissue such that the radiation beams emitted from each wand simultaneously pass approximately through a region located in the tissue.
- the apparatus further includes a controller, a control panel, a power source, and components configured to vary the radiation power and energy, pulse frequency, pulse duration, and duration of the biostimulation treatment.
- FIG. 1 is a perspective view, in reduced scale, of a biostimulation device incorporating a therapeutic laser apparatus of the present invention
- FIG. 2 is a diagrammatic representation of the operation panel of the therapeutic laser apparatus of FIG. 1;
- FIG. 3 is a cross-sectional view, in enlarged scale, of the laser wands of FIG. 1;
- FIG. 4 is a schematic functional representation of the laser radiation sources of the therapeutic laser apparatus of FIG. 1;
- FIG. 5 is a schematic functional representation of the major sub-components of the therapeutic laser apparatus of FIG. 1;
- FIGS. 6A and 6B are functional descriptions of the method of operation of the therapeutic laser apparatus of the present invention.
- FIG. 7 is a side view of an embodiment of the laser wands of the apparatus of FIGS. 1 & 2, in enlarged scale, in operation and directed towards a human knee undergoing therapeutic biostimulation.
- the sources of radiation are preferably semiconductor laser diodes, super-luminous diodes, or light emitting devices, and more preferably are solid-state laser diodes (SSDs).
- Laser diodes or SSDs produce a beam of light or radiation that is essentially monochromatic, sharply collimated, and coherent. That is, they produce light almost exclusively at one frequency and the light beam has a small angle of divergence.
- the preferred embodiment of the present invention is a device 10 for biostimulation of biological tissue that includes a controller cabinet 20 that houses various subcomponents.
- the cabinet 20 may be mounted to a roller pedestal 30 and it is, in one embodiment, connected to an operator safety pedal 40 and a plurality of laser treatment wands 50 that may be received into a laser radiation shielding receptacle 60 .
- the receptacle 60 may be mounted to the cabinet 20 .
- the cabinet is formed with a control panel 70 that includes various input and output devices needed for operating the device 10 .
- the invention contemplates a room entry-way safety interlock.
- the safety interlock connects a safety switch mounted to the door-way of the room that houses the therapeutic laser device to the device 10 .
- the safety switch is configured to de-energize all or some of the laser radiation sources upon opening of the door to the room. Inadvertent injury is prevented because laser radiation cannot escape the treatment room.
- the entry-way safety interlock is connected to the device 10 and may be portably mounted on any door-way so that the device 10 nay be easily moved between a plurality of treatment rooms.
- pedal 40 is shown in the various figures, the pedal 40 may be accompanied by or entirely replaced by a safety switch mounted on either or both of the laser treatment wands described below.
- control panel 70 further includes a master power switch 80 , an emergency stop switch 85 , and an operator's safety arming key switch 90 . If the arming key is removed from the switch 90 , power to laser radiation sources of the device 10 is interrupted to prevent operation of the lasers. Also included on the control panel is a mode switch 95 configured to operate the device 10 in either single or dual laser mode.
- a numeric entry keypad 100 similar in design to a typical telephone keypad is mounted on the control for configuring the various operating parameters of the device 10 as described in more detail below.
- the keypad 100 is preferably a hermetically sealed, membrane keypad.
- a resume switch 105 is also included that is operative to continue interrupted operation.
- An output display group on the control panel 70 includes various component status indicators.
- the indicators include, for example, light emitting diodes (LEDs) 110 , liquid crystal alphanumeric displays (LCDs) 115 , 120 , and audio emitting event buzzers, not shown, each operative to signal component and system status, to prompt the operator for needed input, and to warn of system anomalies and malfunctions.
- the LCDs are, for example, back-lit, 4 line ⁇ 20 character displays.
- the indicators can also indicate the status of the foot pedal 40 and whether any access panels or doors of the main cabinet 20 are open. All access panels or doors of the main cabinet 20 incorporate interlock sensors operative to disconnect power to the laser radiation sources or the device 10 , or both, for safety. Additional LEDs 110 and LCDs 115 , 120 may also be incorporated to signal that the treatment room door is open or ajar.
- each of the treatment wands 125 , 130 of the plurality 50 is connected via fiber optic cables 135 , 140 to radiation sources, not shown, inside the cabinet 20 .
- the preferred fiber optic cable for use with the present invention is approximately a 400 micron fiber.
- each treatment wand 125 , 130 incorporates a collimator lens 145 operative to focus the treatment laser beam emitted from the fiber optic cables 135 , 140 into the desired beam shape and to project the beam outwardly.
- the wands each also include an adjustable collimator holder 150 that can be adjusted to vary the shape and focus of the emitted beam.
- An example of the preferred collimator 145 is an aspheric collimator lens having a focal length of approximately 6.25 millimeters. Typical laser radiation energy losses at each surface of the collimator 145 are, on average, about 4 percent. Therefore, each lens surface 146 , 147 preferably includes an anti-reflection coating adapted to minimize the losses at each surface to approximately 0.5 percent. Additionally, the collimator 145 and the holder 150 are arranged to preferably emit a generally circular beam spot having an approximately 4 millimeter diameter.
- the wands are preferably about 5 to 6 inches in length and are made of aluminum. However, they can be made from any suitable material including, for example, metal, plastic, ceramic, glass, and combinations thereof.
- each treatment wand 125 , 130 emits laser radiation energy transmitted from at least one of a plurality of laser radiation sources 155 that are preferably contained in a single unit, heat sinked assembly 180 .
- the laser radiation sources are selected to emit infrared or visible laser radiation, or both.
- infrared treatment laser radiation from one source 165 of the plurality 155 is combined with visible laser radiation from another source 170 of the plurality 155 and transmitted into at least one of the fiber optic cables 135 , 140 .
- Laser radiation sources suitable for use with the present invention include a high-power, Class 4, infrared wavelength SSD laser and a Class 1 or 2, visible wavelength SSD laser available from B. & W. Tek, Inc. of Newark, Del., U.S.A. Each of these sources is combined into the single unit assembly 180 .
- the assembly 180 incorporates a power supply 185 , 190 for each laser radiation source 165 , 170 .
- a combiner 195 configured to combine the invisible and visible laser radiation energy into a single fiber optic cable 135 , 140 via a releasable, SMA 906 compliant, fiber optic coupler 200 .
- Each of the infrared treatment laser radiation sources 165 is adapted to emit Class 4 infrared treatment laser radiation with an adjustable power of preferably between approximately zero and approximately 10.0 watts, and more preferably between approximately zero and approximately 5.0 watts, and even more preferably between approximately zero and approximately 2.0 watts. This capability assures an emitted infrared treatment laser radiation power at the treatment end of each of the wands 125 , 130 of preferably between about zero and approximately 2.0 watts. These parameters account for many variables including the ability of the biological tissue to absorb radiation and the unavoidable power losses in the combiner 195 , coupler 200 , cables 135 , 140 , and wands 125 , 130 . Additionally, each of the infrared treatment laser radiation sources 165 is further configured to emit laser radiation having a wavelength preferably between approximately 900 nanometers (“run”) and approximately 1100 nm, and more preferably approximately 980 nm.
- Each of the visible laser radiation sources 170 is preferably configured to emit Class 1 to Class 2 laser radiation with either a fixed or adjustable power of approximately 0.5 milliwatts to approximately 6 milliwatts. This capability assures a visible emitted laser radiation power at the treatment end of each of the wands 125 , 130 including the unavoidable power losses in the combiner 195 , coupler 200 , cables 135 , 140 , and wands 125 , 130 . Additionally, each of the visible laser radiation sources 170 is also configured to emit radiation having a wavelength preferably between approximately 400 nm to approximately 700 nm, and more preferably between about 635 nm and about 640 nm.
- the plurality 155 contemplates any number of greater and fewer laser sources configured to emit laser radiation at various power levels and wavelengths for one or more wands or therapeutic treatment applicators or emitters.
- a circular beam shape of approximately 4 mm is disclosed, a wide variety of feathered, diffused, Fresnel, traced, and other types of spread-out patterns are also suitable for use with the present invention.
- Such patterns also include rectangular, square, oval, and elliptical patterns, as well as predetermined or random movably scanned or traced beam patterns that are adapted to be spread over a selected region or to trace a specific shape or pattern.
- the cabinet 20 incorporates various components interconnected with the control panel 70 , the laser radiation sources 155 and wands 125 , 130 , and the foot pedal 40 .
- the components are configured to control the laser radiation sources 165 , 170 for therapeutically effective biostimulation of human, animal, and experimental biological tissues.
- the device 10 includes a single board computer or controller component 210 that is preprogrammed to control each of the other components and functions of the device 10 .
- One example of a suitable controller 210 is the BASIC Stamp II-SX microcontroller and accompanying chip set from Parallax, Inc., of Rocklin, Calif., U.S.A.
- the controller 210 electronically communicates with a year 2000 compliant clock such as the Pocket Watch B 220 from Solutions 3 (Solutions Cubed) of Chico, Calif., U.S.A., the audio emitter 170 , and the LCDs 115 , 120 .
- the controller 210 communicates directly with the laser radiation sources 155 through both a multiplexer interface circuit 230 and an information bus interface circuit 235 such as, for example, the I 2 C serial bus chip set available from Philips Semiconductors of Sunnyvale, Calif..
- the keypad 100 electronically communicates with the controller 210 via the bus 235 through a decoder circuit 240 and an 8-bit, quasi-bidirectional expander 245 .
- the indicators 110 and the switches 80 , 85 , 90 , 95 , 105 also communicate with the controller 210 via the bus 235 through converters 245 .
- An example of a decoder circuit or chip set 240 suitable for use in the present invention is the model 74HC147 chip available from Harris Semiconductor, Inc. of Palm Bay, Fla., U.S.A.
- An example of a suitable 8-bit, quasi-bidirectional expander circuit or chip set 245 is the model PCF8574 I 2 C bus compatible chip set available from Philips Semiconductors.
- the controller 210 also communicates with and controls the power, duration, pulse frequency, and pulse width or duty cycle of the laser radiation sources 155 through the bus 235 , and through various interface circuits.
- the primary interface circuit stage includes dual, independently operable 8-bit digital-to-analog converters 250 , 255 .
- the first converter 250 is configured to provide a controlled output voltage of between approximately zero volts and approximately 1.25 volts and is adapted to drive the power output of the laser sources 155 .
- the second converter 255 is configured to provide a controlled output of between approximately zero volts and 5 volts and is adapted to drive a laser pulse frequency and duty cycle interface circuit.
- One example of an adequate converter 250 , 255 is the model PCF8591 I 2 C bus compatible converter also available from Phillips Semiconductors.
- the converter 255 drives a voltage controlled oscillator (“VCO”) 260 configured to output a signal modulated between approximately 100 Hertz (“Hz”) and 1,000 Hz.
- VCO voltage controlled oscillator
- a suitable VCO 260 is the model AD654 VCO available from Analog Devices, Inc. of Norwood, Mass., U.S.A.
- the VCO 260 electronically communicates with a pulse width modulator (“PWM”) circuit or chip set 265 that can be obtained as the model PALCE610 PWM available from Vantis Semiconductor, Inc. (formerly Altera Corporation) of San Jose, Calif..
- PWM pulse width modulator
- the PWM 265 also communicates with the multiplexer 230 , through the laser driver interface 270 , and with the laser radiation sources 155 .
- the operator may select a frequency of one hertz (cycles per second) and a pulse width of 50%.
- the pulse width is adjustable between approximately 0.1% and 100%.
- the controller 210 would then set the laser radiation source or sources to have a pulse frequency of one cycle per second wherein the radiation pulse or pulses are on for 0.5 seconds and off for 0.5 seconds.
- the controller 210 may also be programmed to adjust the power wattage levels and joule energy levels, as well as the continuous wave or pulsed wave operation of each of the laser radiation sources synchronously or independently. Continuous wave operation is selected by specifying a pulse width or duty cycle of 100%.
- the controller 210 may be programmed to limit the maximum time of treatment to, for example, 60 minutes. Additionally, the operator may similarly adjust the power level or “brightness” of the visible laser radiation sources and to select a pulsed or continuous wave operation.
- the controller 210 also preferably electronically communicates with a hardware reset switch and a serial port interface circuit, not shown, but incorporated into the back plane of the cabinet 20 .
- the hardware-reset switch is preferably operative to perform a low-level system reset in the event of hardware or software anomalies in device 10 .
- the serial port is configured to communicate with the controller 210 for purposes of external software control of the device 10 or its components, e.g., the lasers, or both. Also, the serial port can be configured to allow remote monitoring of device diagnostics, and to upload software upgrades to the device 10 .
- the device 10 is operated by first energizing the power switch 80 on the control panel 70 .
- the preprogrammed logic of the controller 210 initiates a system self-test subroutine 300 and displays progress, system status, and operator welcome messages 310 on the LCDs 115 , 120 .
- the logic programmed into the controller 210 next scans the status 315 of the arming key switch 90 .
- An operator's key must be inserted into the arming switch 90 before any of the laser radiation sources 165 , 170 can be energized.
- the controller 210 continuously scans the arming switch 90 and automatically detects when the switch has been energized. Once energized, the controller 210 next executes a user prompt routine 320 that displays operator prompts on the LCDs 115 , 120 requesting the desired parameter settings for the energy dosage in joules, power setting in watts per wand, pulse frequency (if any), and pulse width or duty cycle. After the desired parameters have been entered via the keypad 100 , the controller 210 continues to execute routine 320 to compute the time required to accomplish the procedure according to the entered parameters. After the time computation is completed, routine 330 executes to energize the visible light and aiming laser radiation sources 170 .
- the laser wands 125 , 130 can be aimed because the visible wavelength laser beams are emitted from the wands. If the mode switch 95 has been adjusted to select single laser operation, then only one of the aiming laser radiation sources 170 will be energized. In alternative embodiments, although not shown in the figures, either an analog switch or a keypad 100 entry can be made to adjust the intensity of the aiming laser radiation sources 170 , if needed.
- routine 335 is executed to ensure the key switch 90 remains energized, routine 340 is executed to ensure that all access doors are closed, and routine 345 is executed to make sure the foot pedal 40 is depressed. If all safety checks do not pass, then control is returned to routine 335 . If the key switch 90 is no longer energized, then the aiming laser radiation sources are de-energized by routine 350 and control passes back to the welcome message prompt routine 310 . Also, although not reflected in the various figures, opening of the treatment room entry door during treatment also executes routine 350 . However, if all safety checks pass, then routine 355 executes to check the mode switch 95 .
- routine 360 or 365 is executed to energize either one or both therapeutic laser radiation sources 165 . If additional laser radiation sources are available, then the mode switch would be adjusted to establish which of the plurality of laser radiation sources were to be energized.
- routine 370 executes to check the key switch 90 . If de-energized, control passes to routine 375 to de-energize all of the lasers 165 , 170 and control passes to the welcome message prompt routine 310 . Otherwise, routines 380 , 385 , and 390 execute to respectively check to ensure all access doors and panels remain closed, that the pedal 40 remains depressed, and to check if the mode switch 95 has been adjusted. If any of the cabinet doors or access panels have been opened, routine 395 executes to de-energize all of the laser radiation sources 165 , 170 . Although not reflected in the various figures, opening of the treatment entry door during treatment also executes routine 395 .
- routine 400 executes and sends a message to either or both of the LCDs 115 , 120 , and, if desired, a signal to the audio emitter 170 .
- the operator may respond to the prompts and alerts by depressing the resume switch 105 , returning control to routine 330 to initiate the series of pre-energization safety checks.
- routine 385 determines that the foot pedal 40 is no longer depressed, control passes to the “all lasers off” routine 395 and then to the pause-resume routine 400 .
- mode switch check routine 390 executes to poll the mode switch 95 . If the switch 95 has been adjusted, then the second laser radiation source is accordingly energized by routine 405 or de-energized by routine 410 . Operation control then proceeds to counter routine 420 which increments the time remaining for the procedure as calculated initially by routine 320 . Control then passes to timer routine 430 . If the duration of time needed to complete the procedure has passed, then routine 435 executes to de-energize all laser radiation sources 165 , 170 .
- routine 440 which sends a signal to the audio emitter 170 , if desired, and displays prompts on the LCDs 115 , 120 , to determine whether the therapeutic laser application procedure should be repeated. If not, control passes to the operator prompt routine 320 . If the operator elects to repeat the procedure, then control is transferred to routine 330 , and the above operations are repeated.
- the present invention also includes a method for treatment of tissue.
- the method involves exposing the tissue to a plurality of radiation sources having a wavelength of between approximately 900 nm and approximately 1100 nm. More generally, the method of treatment of the present invention involves the exposure of the tissue to a plurality of converging beams of infrared radiation of between about 900 nm and 1100 nm. Any embodiment of the device of the present invention, including but not limited to those previously described, can be used to perform this method of treatment.
- the operator hands are shown holding the laser wands 125 , 130 above the biological tissue “A” to be treated.
- the wands 125 , 130 are preferably positioned so the beams intersect at a region “B” of the biological tissue “A” undergoing treatment.
- the wands 125 , 130 are preferably oriented at an angle ⁇ (alpha) relative to each other and an angle ⁇ (theta) to an imaginary, approximately horizontal reference line “C” passing through the tissue undergoing treatment so that the beams 127 , 132 intersect.
- intersection of the emitted infrared, treatment laser radiation significantly improves the absorption of the energy by the tissue at and proximate to the region or point of intersection “B” of the beams 127 , 132 .
- the operator preselects the region or regions to be treated and may vary the location of the intersection region “B” by adjusting the position and orientation of the wands 125 , 130 .
- Obstacles to radiation penetration should be preferably removed before treatment because they may absorb, refract, reflect, and/or diffract the incident radiation, and thereby decrease radiation penetration
- the invention also contemplates an automatic positioning device configured to fixedly and/or changeably adjust the position and orientation of the wands 125 , 130 relative to one another and relative to the biological tissue undergoing therapeutic laser treatment.
- the positioning device is configured to adjust position and orientation of the wands 125 , 130 into an operative position with the emitted aiming and therapeutic laser beams having an intersection region within the biological tissue receiving the treatment similar to the description above and in FIG. 7.
- the positioning device may include an assembly operative to automatically vary the relative positions and orientation of the wands 125 , 130 during the therapeutic laser application.
Abstract
The therapeutic laser apparatus (10) includes at least two wands (50) connected to a controller (210) and radiation source (155) via fiber optic cables (135, 140). The controller (210) and source (155) include at least two infrared wavelength solid-state diode (“SSD”) lasers (165) and at least two visible wavelength SSD aiming lasers (170). The apparatus (10) further includes a combiner (195) configured to maintain the electromagnetic radiation from one infrared SSD laser (165) coincident with one visible light SSD aiming laser (170). In the method according to the invention, the visible light SSD aiming laser (170) is used as a pointer so that an operator can position wands (125, 130) adjacent to the skin of a mammal whereby the beams (127, 132) of infrared treatment lasers (165) intersect at a region (B) inside the body (A) of the mammal.
Description
- This application is a continuation application of U.S. patent application Ser. No. 09/281,443 filed Mar. 29, 1999, now U.S. Pat. No. 6,______ issued,______, 2001.
- The invention is directed to an apparatus and a method for applying laser beam energy in the treatment of medical conditions. More specifically, the present invention is concerned with an apparatus that uses wands emitting visible laser beam energy and invisible infrared laser beam energy. The method of the invention comprises positioning the wands over the patient in a manner such that the infrared radiation from the wands intersects within the body of the animal that is subjected to therapy.
- The application of laser beam energy in the treatment of medical conditions has been investigated since the early 1970's. Numerous investigators have demonstrated that the application of low power laser beam energy on the order of 1 to 100 milliwatts and at varying wave lengths (e.g., 700-1100 nanometers) (“nm”) is effective in the treatment of various medical conditions. Low-level laser beam energy has been shown to enhance wound healing and reduce the development of scar tissue after surgical procedures. Such energy has also been shown to relieve stiff joints and promote the healing of injured joints, stimulate the body's ability to heal fractures and large contusions, as well as enhancing the healing of decubitus ulcers.
- Medical and dental applications for low level laser beam energy of varying wave lengths also include pain control, nerve stimulation, reduction of edema, reduction of inflammation, arthritis, muscle and tendon injuries, and stimulation of the body's neurohormone system. Other applications have demonstrated increased activity in cells specifically connected with the immune system and antigen response.
- The mechanisms of how the tissues of a mammal respond to low power laser beam energy is not well elucidated or understood. Therapeutic laser treatments of humans, animals, and biological tissues have been commonly referred to as “photobiostimulation” treatments. Suggestions have been made that the process of photobiostimulation accelerates the initial phase of wound healing by altering the levels of prostaglandins. It has also been suggested the laser beam energy increases ATP synthesis, accelerates collagen synthesis, and increases the ability of immune cells to ward off invading pathogens. See, e.g., Bolognami et al., “Effects of GaAs Pulsed Lasers on ATP Concentration and ATPase Activity In Vitro and In Vivo,” International Cong. On Lasers in Medicine and Surgery, p. 47 (1985); Karu and Letokhov, “Biological Action of Low-Intensity Monochromatic Light in the Visible Range,” Laser Photobiology and Photomedicine, ed. Martellucci, pp. 57-66 (Plenum Press 1985); Passarella et al., “Certain Aspects of Helium-Neon Laser Irradiation on Biological Systems in Vitro,” Ibid. at pp. 67-74.
- Conventional low power (less than 100 milliwatts) laser therapeutic devices generally comprise a hand held probe with a single laser beam source, or a large stationary table console with attached probes powered by a conventional fixed power supply. A common laser beam source is the laser diode. Laser diodes are readily available in varying power and wavelength combinations. Large probes containing multiple laser diodes are also known.
- Isakov et al., in U.S. Pat. No. 4,069,823, disclose an apparatus for laser therapy including one or several lasers, a light guide and a focusing barrel wherein there are at least two platforms for transverse and longitudinal travel so that tissue can be dissected. The patent also discloses the use of a visible light beam that coincides with the laser beam thus allowing the surgeon to accurately aim the invisible laser beam to the required point. CO2 lasers with wavelengths in the area of 1060 nm are employed. This patent also suggests laser beam densities of up to 105 watts per square centimeter.
- Kanazawa et al. disclose in U.S. Pat. No. 4,640,283, a method of curing athlete's foot by laser beam irradiation. This patent discloses the use of a laser such as a CO2 laser or a YAG laser that emits a laser beam in the infrared region having a wavelength of 700 nm or more. Energy levels are disclosed as two joules per centimeter squared or more for a period of ten milliseconds or less. This patent does not suggest or disclose the use of an apparatus including at least two wands for the laser therapy of medical conditions such as arthritis and bursitis.
- Muchel in U.S. Pat. No. 4,699,839 discloses an optical system for therapeutic use of laser light. The Muchel instrument provides for combined observation of and laser treatment of a portion of a human body, such as an eye. This patent discloses the construction of main objective lenses within certain parameters adapted to combine laser therapy radiation from multiple sources. One source emits radiation having a wavelength of, for example, 1064 nm. A second source emits laser target light radiation having a wavelength of 633 nm. And a third source emits an observation light in the visible spectrum range of from 480 nnl to 644 nm.
- U.S. Pat. No. 4,671,285 to Walker discloses the treatment of human neurological problems by laser photo simulation. This patent relates to a method of treating nerve damage in humans by applying an essentially monochromic light to the skin area adjacent to the damaged nerve region. The inventor describes the use of a helium neon laser (632.5 nm, 1 milliwatt, and 20 hertz) with a fiber optic probe, which is held against the skin of the patient. The inventor also states that irradiation with infrared lasers (1090 nm) had no effect. This reference actually teaches away from the present invention.
- Liss et al. teach in U.S. Pat. No. 4,724,835 a therapeutic laser device using a pulsed laser wave. The Liss et al. device uses a gallium aluminum arsenide diode as the source of laser energy that is in the infrared band (wavelength of approximately 900 nm).
- U.S. Pat. No. 4,396,285 to Presta et al. relates to a laser system for medical applications that has at least two lasers and a movable concave reflector. One of the beams, an imaging beam, is aligned to impinge on the reflector, to reflect therefrom and to impinge on a biological specimen. The reflector is moved until the beam is aligned to impinge on the desired location of the specimens. The second beam is also aligned to impinge on the reflector to reflect therefrom and to impinge on the same desired position as that impinged upon by the first beam. The second laser is typically disclosed to be a CO2 laser that generates the second beam having a wavelength of 10.6 microns. The Presta system is disclosed as being useful for microsurgery. This reference does not disclose a laser therapy apparatus wherein the therapeutic radiation and the targeting radiation are merged so as to be coincidental on the surface of the patient's skin and at least two wands for positioning the intersection of the beams within the body of the patient.
- U.S. Pat. No. 4,930,504 to Diamantopoulos et al. relates to a device for biostimulation of tissue which comprises an array of monochromic radiation sources of a plurality of wavelengths, preferably at least three different wavelengths. For example, this patent discloses the treatment of patients with a multi-diode biostimulation device having emitted frequencies of 660 nm, 820 nm, 880 nm, and 950 nm. The power levels disclosed are between 5 milliwatts and 500 milliwatts. This patent also discloses obtaining the radiation from a plurality of sources whose outputs are combined to a single emergence region with flexible optic fibers.
- Labbé et al., in U.S. Pat. No. 5,021,452, disclose a process for improving wound healing which comprises administering ascorbate or derivatives of ascorbate to the wound site and then irradiating the wound site with a low power laser at a wavelength of about 600 nm to about 1100 nm. This patent discloses that the laser can either be a pulsed or a continuous wave laser with energy outputs ranging from 1.0 millijoule per square centimeter to about 1000 millijoules per square centimeter. This reference does not suggest or disclose an apparatus including at least two wands with a combined beam of therapeutic radiation and targeting radiation which are used to intersect the therapeutic radiation beams within the body of the animal subject to treatment.
- U.S. Pat. No. 5,147,349 to Johnson et al. discloses a diode laser device for photocoagulation of the retina. The inventors disclose that the elliptical laser beam is shaped into a circle by an optical system before it is coupled to the fiber optic cable of the delivery system.
- Mendes et al. in U.S. Pat. No. 5,259,380, discloses a light therapy system utilizing an array of light emitting diodes which emit non-coherent light in a narrow band width centered at a designated wavelength. The non-coherent light is generated by an array of conventional light emitting diodes with wavelengths in the red or infrared bandwidth. Infrared frequencies in the area of 940 nm, more particularly 880 nm are disclosed.
- U.S. Pat. No. 5,409,482 to Diamantopoulos discloses a probe for biomodulation. The probe includes a semiconductor laser and a drive circuit adapted to operate the laser to emit pulses and bursts. The system according to this patent has a laser beam wavelength of 850 nm and a frequency of 352×103 GHz pulsed at 300,000 and additionally modulated at a frequency of from 1 Hz to 2 GHz
- Bellinger in U.S. Pat. No. 5,445,146 describes a laser system for the stimulation of biological tissue that emits radiation with a power of from 100 to 800 milliwatts in either a pulsed or continuous mode. The laser disclosed has a fundamental wavelength of 1064 nm and delivers an energy density of from about one joule per square centimeter to about 15 joules per square centimeter.
- Smith in U.S. Pat. No. 5,464,436 discloses a laser therapy apparatus having a wavelength in the range of 800 to 870 nm and more preferably about 830 nm. The laser light is delivered to the afflicted area at a level of about one joule per square centimeter. Smith also suggests that the afflicted area be monitored after the treatment cycle and that treatment steps be repeated to the afflicted area.
- U.S. Pat. No. 5,527,350 to Grove et al. discloses a method for treating psoriasis through the use of pulsed infrared laser irradiation. An infrared diode laser is used having a wavelength of 800 nm and a pulse duration in the millisecond range. Energy levels of 5.0 to 50 joules per square centimeter are disclosed.
- U.S. Pat. No. 5,616,140 to Prescott discloses a portable laser bandage having one or many lasers or hyper-red light emitting diodes embedded in the bandage. The hyper-red light emitting diodes are disclosed as having wavelengths of about 670 nm.
- PCT Application PCT/US93/04123 (WO 93/21993) discloses a low level laser for soft tissue treatment wherein the laser is a Nd:YAG laser, which produces 100 to 800 milliwatts in a pulsed or continuous mode.
- In an article entitled: “Low-Intensity Laser Reduces Arthritis Symptoms” by Pfieiffer in the Journal of Clinical Laser Medicine & Surgery, Vol. 10, No.6, (1992), the author reviews various clinical studies using infrared and red lasers in the treatment of arthritis. This publication makes no disclosure of any specific laser therapy apparatus.
- In a research report by Beckerman et al. entitled: “The Efficacy of Laser Therapy for Musculoskeletal and Skin Disorders: A Criteria-Based Meta-analysis of Randomized Clinical Trials,” Physical Therapy, Vol. 72, No.7, July, 1992, the authors review the results of 36 randomized clinical trials involving laser therapy. The article concludes that laser therapy seems to have a substantial, specific therapeutic effect. The authors also point out that it is difficult to determine the optimal dosage and treatment schedules. Further, the authors note that the minimal effective dosage in most cases is unknown and that additional questions need to be resolved regarding the optimal wavelength.
- While a substantial amount of prior art exists regarding the use of laser therapies in medical conditions, no one has described or suggested an apparatus that comprises at least two wands that emit coincident visible and infrared radiation, wherein the infrared radiation has a wavelength of about 1000 nm. Further, none of the prior investigators have suggested aiming the at least two wands on the surface of the animal being treated so as to have the therapeutic infrared radiation beams intersect inside the animal's body at the site of therapy.
- The therapeutic laser apparatus according to the invention has at least two independent fiber optic laser outputs terminating with wands that have apertures with variable foci. The inventive apparatus also has a main function block wherein the therapeutic infrared radiation is combined with visible laser light and fed into fiber optic cables via couplers. The fiber optic cables transmit the radiation to the wands. The main function block also contains at least two infrared diode lasers and at least two red diode lasers. Through the design of at least two wands, a novel method of therapy has been discovered wherein the patient or caregiver positions the wands in such a manner that the infrared radiation (at about 1000 nm) from the wands intersects at the point of therapy (inside the body), thereby relieving pain and promoting regeneration of tissue.
- The amount of energy applied by each wand can range from about 200 to about 2,000 milliwatts. Preferably, the wands are held in each hand of the caregiver at an angle of about 45° relative to the plane of the patient or biological tissue undergoing treatment. The wands are slowly moved in small circular motions favoring positions that allow the beams of laser radiation to intersect in the body at the site of the malady. As will be disclosed below, the apparatus according to the invention can be effectively used to treat joints affected by arthritis and sore muscles. Patients with advanced forms of degenerative arthritis have experienced pain relief and, over time, revitalization of joints previously affected by the disease.
- The concept of using heat (infrared radiation) for relief from pain has been practiced for thousands of years. Electrically heated pads have found wide spread use for pain relief on all parts of the human body and this application of infrared radiation for pain relief is usually referred to as diathermy. It has been discovered that the treatment of a patient with a device according to this invention is not simply receiving heat treatment or diathermy. The actual body mechanisms responsible for relief from pain and revitalization of joints and other tissue are not completely understood. The inventors have observed that the treatments with this particular wavelength of about 1,000 nm and the delivery mechanism of at least two wands is especially effective in the treatment of arthritis.
- In the main function block, two infrared diode lasers and two red diode lasers are preferably coupled so that these two frequencies are transmitted to the wands via the fiber optic cable. The combined infrared laser radiation and the visible laser light exit the treatment aperture in the wand coincident and therefore provide an excellent aiming mechanism to the caregiver or patient.
- The diameter of the fibers used in the apparatus according to the invention may vary over a wide range. However, the diameter is preferably between approximately 400 microns and approximately 800 microns, and more preferably approximately 600 microns, and even more preferably approximately 400 microns. The preferred wavelength of the infrared lasers is between approximately 900 nm and approximately 1100 nm with the best results being obtained with a wavelength of about 980 nm. The low power visible aiming laser component is typically a red diode laser having a wavelength of between about 400 nm and about 700 nm, and more preferably between about 635 nm and about 640 nm. The wavelength of approximately 635-640 nm is preferred because of its high visibility and minimized effect on the human eye. The power output per wand can range from about 0.0001 milliwatts watts to about 2.0 watts.
- Thus, there is disclosed a device for biostimulation of biological tissue that includes
- a) at least two radiation sources emitting a first wavelength of between approximately 900 nm to approximately 1100 nm;
- b) at least two radiation sources emitting a second wavelength of between approximately 400 nm to approximately 700 nm; the radiation sources being arranged such that the first and second wavelengths simultaneously pass through a fiber optic cable; and
- c) at least two wands connected to the fiber optic cable and having apertures having variable focus; the wands being arranged such that the coincident first wavelength and second wavelength emitted from each wand pass through a region located within the tissue.
- There is further disclosed a method for the treatment of tissue including:
- a) providing at least two infrared laser radiation sources having a wavelength of between approximately 900 nm to approximately 1100 nm;
- b) providing at least two sources of laser radiation having a wavelength between approximately 400 nm and 700 nm;
- c) combining the radiation sources so that the radiation of each source is coincident;
- d) passing the coincident radiation through an optical fiber;
- e) providing at least two wands connected to the optical fiber;
- f) arranging the wands such that the radiation emitted from each of the wands passes through a region located within the tissue; and
- g) exposing the tissue to an irradiation beam for a therapeutically effective period of time.
- Also disclosed is a device for photobiostimulation of biological tissue that includes:
- a) a first plurality of treatment radiation sources each emitting a respective first radiation beam having a wavelength of between approximately 900 nm and approximately 1100 nm;
- b) a second plurality of aiming radiation sources each emitting a respective second radiation beam having a wavelength of between approximately 400 nm and approximately 700 nm; wherein at least one first beam and one second beam concurrently pass through at least one of a plurality of fiber optic cables; and
- c) at least two wands each connected to a different one of the plurality of fiber optic cables, the wands including a collimator configured to establish the focus of the emanating coincident radiation beams; wherein the wands are arranged in an operative position about the tissue such that the radiation beams emitted from each wand simultaneously pass approximately through a region located in the tissue.
- The invention also contemplates and discloses a biostimulation device that includes a laser apparatus including a plurality of treatment laser wands each connected to a laser radiation source adapted to emit radiation having a power of between about zero and approximately 2.0 watts, an energy of between about 1 joules and about 99 joules, and a wavelength of between approximately 900 nm and 1100 nm; and wherein the laser wands are arranged in an operative position to emit the radiation incident to a region of biological tissue for a therapeutically effective length of time between approximately one and approximately sixty minutes.
- Further, a system for photobiostimulation of biological tissue is disclosed. The system includes a controller unit including a power supply and a control panel having operator input devices and output devices;
- the controller unit also including a first plurality of treatment radiation sources each emitting a respective first radiation beam having a wavelength of between approximately 900 nm and approximately 1100 nm;
- the controller unit also including a second plurality of aiming radiation sources each emitting a respective second radiation beam having a wavelength of between approximately 400 nm and approximately 700 nm; wherein at least one first radiation beam and one second radiation beam concurrently pass through at least one of a plurality of fiber optic cables; and
- at least two wands each connected to a different one of the plurality of fiber optic cables, the wands including a collimator configured to establish the shape of the emanating coincident radiation beams; wherein the wands are arranged in an operative position about the tissue such that the radiation beams emitted from each wand simultaneously pass approximately through a region located in the tissue.
- The apparatus according to the invention further includes a controller, a control panel, a power source, and components configured to vary the radiation power and energy, pulse frequency, pulse duration, and duration of the biostimulation treatment.
- FIG. 1 is a perspective view, in reduced scale, of a biostimulation device incorporating a therapeutic laser apparatus of the present invention;
- FIG. 2 is a diagrammatic representation of the operation panel of the therapeutic laser apparatus of FIG. 1;
- FIG. 3 is a cross-sectional view, in enlarged scale, of the laser wands of FIG. 1;
- FIG. 4 is a schematic functional representation of the laser radiation sources of the therapeutic laser apparatus of FIG. 1;
- FIG. 5 is a schematic functional representation of the major sub-components of the therapeutic laser apparatus of FIG. 1;
- FIGS. 6A and 6B are functional descriptions of the method of operation of the therapeutic laser apparatus of the present invention; and
- FIG. 7 is a side view of an embodiment of the laser wands of the apparatus of FIGS. 1 & 2, in enlarged scale, in operation and directed towards a human knee undergoing therapeutic biostimulation.
- The sources of radiation are preferably semiconductor laser diodes, super-luminous diodes, or light emitting devices, and more preferably are solid-state laser diodes (SSDs). Laser diodes or SSDs produce a beam of light or radiation that is essentially monochromatic, sharply collimated, and coherent. That is, they produce light almost exclusively at one frequency and the light beam has a small angle of divergence. A number of commercially available semiconductor laser diodes exist that are suitable for purposes of the present invention.
- Referring now to FIG. 1, the preferred embodiment of the present invention is a
device 10 for biostimulation of biological tissue that includes acontroller cabinet 20 that houses various subcomponents. Thecabinet 20 may be mounted to aroller pedestal 30 and it is, in one embodiment, connected to anoperator safety pedal 40 and a plurality oflaser treatment wands 50 that may be received into a laserradiation shielding receptacle 60. For convenience, thereceptacle 60 may be mounted to thecabinet 20. The cabinet is formed with acontrol panel 70 that includes various input and output devices needed for operating thedevice 10. - Also, although not shown in the various figures, the invention contemplates a room entry-way safety interlock. The safety interlock connects a safety switch mounted to the door-way of the room that houses the therapeutic laser device to the
device 10. The safety switch is configured to de-energize all or some of the laser radiation sources upon opening of the door to the room. Inadvertent injury is prevented because laser radiation cannot escape the treatment room. In the preferred embodiment, the entry-way safety interlock is connected to thedevice 10 and may be portably mounted on any door-way so that thedevice 10 nay be easily moved between a plurality of treatment rooms. Additionally, althoughpedal 40 is shown in the various figures, thepedal 40 may be accompanied by or entirely replaced by a safety switch mounted on either or both of the laser treatment wands described below. - With continued reference to FIG. 1 and also FIG. 2, it can be understood that the
control panel 70 further includes amaster power switch 80, anemergency stop switch 85, and an operator's safety armingkey switch 90. If the arming key is removed from theswitch 90, power to laser radiation sources of thedevice 10 is interrupted to prevent operation of the lasers. Also included on the control panel is amode switch 95 configured to operate thedevice 10 in either single or dual laser mode. Anumeric entry keypad 100 similar in design to a typical telephone keypad is mounted on the control for configuring the various operating parameters of thedevice 10 as described in more detail below. Thekeypad 100 is preferably a hermetically sealed, membrane keypad. Aresume switch 105 is also included that is operative to continue interrupted operation. - An output display group on the
control panel 70 includes various component status indicators. The indicators include, for example, light emitting diodes (LEDs) 110, liquid crystal alphanumeric displays (LCDs) 115, 120, and audio emitting event buzzers, not shown, each operative to signal component and system status, to prompt the operator for needed input, and to warn of system anomalies and malfunctions. The LCDs are, for example, back-lit, 4 line×20 character displays. The indicators can also indicate the status of thefoot pedal 40 and whether any access panels or doors of themain cabinet 20 are open. All access panels or doors of themain cabinet 20 incorporate interlock sensors operative to disconnect power to the laser radiation sources or thedevice 10, or both, for safety.Additional LEDs 110 andLCDs - Each of the
treatment wands plurality 50 is connected viafiber optic cables cabinet 20. The preferred fiber optic cable for use with the present invention is approximately a 400 micron fiber. Referring now to FIG. 3, it will be observed that eachtreatment wand collimator lens 145 operative to focus the treatment laser beam emitted from thefiber optic cables adjustable collimator holder 150 that can be adjusted to vary the shape and focus of the emitted beam. An example of thepreferred collimator 145 is an aspheric collimator lens having a focal length of approximately 6.25 millimeters. Typical laser radiation energy losses at each surface of thecollimator 145 are, on average, about 4 percent. Therefore, eachlens surface collimator 145 and theholder 150 are arranged to preferably emit a generally circular beam spot having an approximately 4 millimeter diameter. The wands are preferably about 5 to 6 inches in length and are made of aluminum. However, they can be made from any suitable material including, for example, metal, plastic, ceramic, glass, and combinations thereof. - With reference to FIG. 4, each
treatment wand laser radiation sources 155 that are preferably contained in a single unit, heat sinkedassembly 180. In the preferred embodiment, the laser radiation sources are selected to emit infrared or visible laser radiation, or both. In the preferred embodiment, infrared treatment laser radiation from onesource 165 of theplurality 155 is combined with visible laser radiation from anothersource 170 of theplurality 155 and transmitted into at least one of thefiber optic cables - In this configuration, the positioning of the invisible infrared laser radiation is emitted coincident with the visible laser radiation so that the operator can properly aim the infrared laser radiation emitted from each
wand Class 4, infrared wavelength SSD laser and a Class 1 or 2, visible wavelength SSD laser available from B. & W. Tek, Inc. of Newark, Del., U.S.A. Each of these sources is combined into thesingle unit assembly 180. In the preferred embodiment of the invention, theassembly 180 incorporates apower supply laser radiation source combiner 195 configured to combine the invisible and visible laser radiation energy into a singlefiber optic cable fiber optic coupler 200. - Each of the infrared treatment
laser radiation sources 165 is adapted to emitClass 4 infrared treatment laser radiation with an adjustable power of preferably between approximately zero and approximately 10.0 watts, and more preferably between approximately zero and approximately 5.0 watts, and even more preferably between approximately zero and approximately 2.0 watts. This capability assures an emitted infrared treatment laser radiation power at the treatment end of each of thewands combiner 195,coupler 200,cables wands laser radiation sources 165 is further configured to emit laser radiation having a wavelength preferably between approximately 900 nanometers (“run”) and approximately 1100 nm, and more preferably approximately 980 nm. - Each of the visible
laser radiation sources 170 is preferably configured to emit Class 1 to Class 2 laser radiation with either a fixed or adjustable power of approximately 0.5 milliwatts to approximately 6 milliwatts. This capability assures a visible emitted laser radiation power at the treatment end of each of thewands combiner 195,coupler 200,cables wands laser radiation sources 170 is also configured to emit radiation having a wavelength preferably between approximately 400 nm to approximately 700 nm, and more preferably between about 635 nm and about 640 nm. - Although only four
laser radiation sources plurality 155 contemplates any number of greater and fewer laser sources configured to emit laser radiation at various power levels and wavelengths for one or more wands or therapeutic treatment applicators or emitters. Additionally, although a circular beam shape of approximately 4 mm is disclosed, a wide variety of feathered, diffused, Fresnel, traced, and other types of spread-out patterns are also suitable for use with the present invention. Such patterns also include rectangular, square, oval, and elliptical patterns, as well as predetermined or random movably scanned or traced beam patterns that are adapted to be spread over a selected region or to trace a specific shape or pattern. - With reference to FIG. 1 and the block-diagram schematic represented in FIG. 5, the
cabinet 20 incorporates various components interconnected with thecontrol panel 70, thelaser radiation sources 155 andwands foot pedal 40. The components are configured to control thelaser radiation sources device 10 includes a single board computer orcontroller component 210 that is preprogrammed to control each of the other components and functions of thedevice 10. One example of asuitable controller 210 is the BASIC Stamp II-SX microcontroller and accompanying chip set from Parallax, Inc., of Rocklin, Calif., U.S.A. Thecontroller 210 electronically communicates with a year 2000 compliant clock such as thePocket Watch B 220 from Solutions3 (Solutions Cubed) of Chico, Calif., U.S.A., theaudio emitter 170, and theLCDs controller 210 communicates directly with thelaser radiation sources 155 through both amultiplexer interface circuit 230 and an informationbus interface circuit 235 such as, for example, the I2C serial bus chip set available from Philips Semiconductors of Sunnyvale, Calif.. Thekeypad 100 electronically communicates with thecontroller 210 via thebus 235 through adecoder circuit 240 and an 8-bit,quasi-bidirectional expander 245. Theindicators 110 and theswitches controller 210 via thebus 235 throughconverters 245. An example of a decoder circuit or chip set 240 suitable for use in the present invention is the model 74HC147 chip available from Harris Semiconductor, Inc. of Palm Bay, Fla., U.S.A. An example of a suitable 8-bit, quasi-bidirectional expander circuit or chip set 245 is the model PCF8574 I2C bus compatible chip set available from Philips Semiconductors. - The
controller 210 also communicates with and controls the power, duration, pulse frequency, and pulse width or duty cycle of thelaser radiation sources 155 through thebus 235, and through various interface circuits. The primary interface circuit stage includes dual, independently operable 8-bit digital-to-analog converters first converter 250 is configured to provide a controlled output voltage of between approximately zero volts and approximately 1.25 volts and is adapted to drive the power output of the laser sources 155. Thesecond converter 255 is configured to provide a controlled output of between approximately zero volts and 5 volts and is adapted to drive a laser pulse frequency and duty cycle interface circuit. One example of anadequate converter - The
converter 255 drives a voltage controlled oscillator (“VCO”) 260 configured to output a signal modulated between approximately 100 Hertz (“Hz”) and 1,000 Hz. Asuitable VCO 260 is the model AD654 VCO available from Analog Devices, Inc. of Norwood, Mass., U.S.A. TheVCO 260 electronically communicates with a pulse width modulator (“PWM”) circuit or chip set 265 that can be obtained as the model PALCE610 PWM available from Vantis Semiconductor, Inc. (formerly Altera Corporation) of San Jose, Calif.. ThePWM 265 also communicates with themultiplexer 230, through thelaser driver interface 270, and with the laser radiation sources 155. - The
controller 210 is programmed to accept operator input from thekeypad 100 and themode switch 95 in response to prompting displayed on theLCDs laser radiation sources 165, and to determine whether continuous wave or pulsed wave operation is needed for the desired therapeutic treatment. Thecontroller 210 then computes the duration of time required for application of the therapeutic laser treatment. To accomplish this computation, thecontroller 210 is programmed, among other aspects, with a power to energy conversion equation that computes time in seconds as a function equal to energy in joules divided by power in watts (T=E×P). If the operator selects pulsed wave operation, thecontroller 210 prompts for the desired frequency and pulse width or duty cycle. As an example, the operator may select a frequency of one hertz (cycles per second) and a pulse width of 50%. In the preferred embodiment, the pulse width is adjustable between approximately 0.1% and 100%. Thecontroller 210 would then set the laser radiation source or sources to have a pulse frequency of one cycle per second wherein the radiation pulse or pulses are on for 0.5 seconds and off for 0.5 seconds. Thecontroller 210 may also be programmed to adjust the power wattage levels and joule energy levels, as well as the continuous wave or pulsed wave operation of each of the laser radiation sources synchronously or independently. Continuous wave operation is selected by specifying a pulse width or duty cycle of 100%. As an additional safety feature, thecontroller 210 may be programmed to limit the maximum time of treatment to, for example, 60 minutes. Additionally, the operator may similarly adjust the power level or “brightness” of the visible laser radiation sources and to select a pulsed or continuous wave operation. - The
controller 210 also preferably electronically communicates with a hardware reset switch and a serial port interface circuit, not shown, but incorporated into the back plane of thecabinet 20. The hardware-reset switch is preferably operative to perform a low-level system reset in the event of hardware or software anomalies indevice 10. The serial port is configured to communicate with thecontroller 210 for purposes of external software control of thedevice 10 or its components, e.g., the lasers, or both. Also, the serial port can be configured to allow remote monitoring of device diagnostics, and to upload software upgrades to thedevice 10. - Referring now to FIGS. 1, 6A, and6B, the
device 10 is operated by first energizing thepower switch 80 on thecontrol panel 70. The preprogrammed logic of thecontroller 210 initiates a system self-test subroutine 300 and displays progress, system status, and operator welcomemessages 310 on theLCDs controller 210 next scans thestatus 315 of the armingkey switch 90. An operator's key must be inserted into the armingswitch 90 before any of thelaser radiation sources - The
controller 210 continuously scans the armingswitch 90 and automatically detects when the switch has been energized. Once energized, thecontroller 210 next executes a user prompt routine 320 that displays operator prompts on theLCDs keypad 100, thecontroller 210 continues to execute routine 320 to compute the time required to accomplish the procedure according to the entered parameters. After the time computation is completed, routine 330 executes to energize the visible light and aiming laser radiation sources 170. At this point, thelaser wands mode switch 95 has been adjusted to select single laser operation, then only one of the aiminglaser radiation sources 170 will be energized. In alternative embodiments, although not shown in the figures, either an analog switch or akeypad 100 entry can be made to adjust the intensity of the aiminglaser radiation sources 170, if needed. - After the aiming
laser radiation sources 170 have been energized, routine 335 is executed to ensure thekey switch 90 remains energized, routine 340 is executed to ensure that all access doors are closed, and routine 345 is executed to make sure thefoot pedal 40 is depressed. If all safety checks do not pass, then control is returned toroutine 335. If thekey switch 90 is no longer energized, then the aiming laser radiation sources are de-energized by routine 350 and control passes back to the welcome messageprompt routine 310. Also, although not reflected in the various figures, opening of the treatment room entry door during treatment also executes routine 350. However, if all safety checks pass, then routine 355 executes to check themode switch 95. If single laser or dual laser operation is selected, then either routine 360 or 365, respectively, is executed to energize either one or both therapeutic laser radiation sources 165. If additional laser radiation sources are available, then the mode switch would be adjusted to establish which of the plurality of laser radiation sources were to be energized. - Once all of the selected lasers have been energized, routine370 executes to check the
key switch 90. If de-energized, control passes to routine 375 to de-energize all of thelasers prompt routine 310. Otherwise,routines mode switch 95 has been adjusted. If any of the cabinet doors or access panels have been opened, routine 395 executes to de-energize all of thelaser radiation sources LCDs audio emitter 170. The operator may respond to the prompts and alerts by depressing theresume switch 105, returning control to routine 330 to initiate the series of pre-energization safety checks. Similarly, ifroutine 385 determines that thefoot pedal 40 is no longer depressed, control passes to the “all lasers off”routine 395 and then to the pause-resume routine 400. - If all doors and panels have not been opened and remain closed and the foot pedal remains depressed, then mode
switch check routine 390 executes to poll themode switch 95. If theswitch 95 has been adjusted, then the second laser radiation source is accordingly energized by routine 405 or de-energized byroutine 410. Operation control then proceeds to counter routine 420 which increments the time remaining for the procedure as calculated initially byroutine 320. Control then passes totimer routine 430. If the duration of time needed to complete the procedure has passed, then routine 435 executes to de-energize alllaser radiation sources audio emitter 170, if desired, and displays prompts on theLCDs prompt routine 320. If the operator elects to repeat the procedure, then control is transferred to routine 330, and the above operations are repeated. - The present invention also includes a method for treatment of tissue. The method involves exposing the tissue to a plurality of radiation sources having a wavelength of between approximately 900 nm and approximately 1100 nm. More generally, the method of treatment of the present invention involves the exposure of the tissue to a plurality of converging beams of infrared radiation of between about 900 nm and 1100 nm. Any embodiment of the device of the present invention, including but not limited to those previously described, can be used to perform this method of treatment.
- Referring next to FIG. 7, the operator hands are shown holding the
laser wands wands wands beams beams wands - Obstacles to radiation penetration, such as oils or other substances on the surface of the skin, should be preferably removed before treatment because they may absorb, refract, reflect, and/or diffract the incident radiation, and thereby decrease radiation penetration
- Although not shown in the figures, the invention also contemplates an automatic positioning device configured to fixedly and/or changeably adjust the position and orientation of the
wands wands wands - From the foregoing, it would be obvious to those skilled in the art that various modifications in the above described method and apparatus can be made without departing from the spirit and scope of the invention. Accordingly, the invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. Present embodiments, therefore, are to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced thereby.
Claims (57)
1. A device for photobiostimulation of biological tissue, comprising:
a) a first treatment radiation source emitting a first radiation beam having a wavelength of between approximately 900 nm and approximately 1100 nm;
b) a second aiming radiation source emitting a respective second radiation beam having a wavelength of between approximately 400 nm and approximately 700 nm; wherein the first beam and the second beam concurrently pass through a fiber optic cable;
c) at least one wand connected to the fiber optic cable, the wand including a collimator configured to adjustably focus the emanating coincident radiation beams; and
wherein the wand is adapted to be arranged in an operative position about the tissue such that the radiation beams emitted from the wand irradiate a region located in the tissue.
2. The biostimulation device of claim 1 , wherein the treatment and aiming radiation sources incorporate light emitting diode lasers.
3. The biostimulation device of claim 1 , wherein the treatment radiation source emits radiation having a wavelength of approximately 980 nm.
4. The biostimulation device of claim 1 , wherein the aiming radiation source emits radiation having a wavelength of between approximately 635 nm and approximately 640 nm.
5. The biostimulation device of claim 1 , wherein the adjustable collimator is further adapted to vary the focus of the emitted radiation beam and the size of the area of irradiated tissue.
6. The biostimulation device of claim 1 , wherein the treatment radiation source is configured to emit adjustably pulsed radiation wherein the pulses have a frequency of between approximately 0.1 cycles per second and approximately 100 cycles per second.
7. The biostimulation device of claim 1 , wherein the treatment radiation source is configured to emit continuous wave radiation.
8. The biostimulation device of claim 1 , wherein the treatment radiation source is configured to adjustably emit pulsed radiation wherein the pulse width is between approximately 0.1 percent and 100 percent.
9. The biostimulation device of claim 1 , wherein the treatment radiation source is configured to adjust the power level of the emitted radiation to have a power of between about zero and approximately 2.0 watts.
10. The biostimulation device of claim 9 , wherein the treatment radiation source is configured to adjust the duration of the therapeutic laser radiation treatment to between approximately 1 second and 3600 seconds.
11. The biostimulation device of claim 1 , wherein the treatment radiation source is configured to adjust the energy level of the emitted radiation to have an energy of between approximately 1 joule and 99 joules.
12. The biostimulation device of claim 11 , wherein the treatment radiation source is configured to adjust the duration of the therapeutic laser radiation treatment to between approximately 1 second and 3600 seconds.
13. A biostimulation device, comprising:
a) a laser apparatus including a plurality of treatment laser wands both connected to a first laser radiation source adapted to emit radiation having a power of approximately between 1 and 10 watts, an energy of between about 1 joule and about 99 joules, and a wavelength of between approximately 900 nm and 1100 nm, and both wands further connected to a second radiation source adapted to emit visible light; and
b) wherein the laser wands are focusable and adapted to be arranged in an operative position to emit the radiation incident to a region of biological tissue for a therapeutically effective length of time.
14. A method for the treatment of tissue, comprising the steps of:
a) providing an infrared laser treatment radiation source having a wavelength of between approximately 900 nm and approximately 1100 nm;
b) providing a source of aiming laser radiation having a wavelength of between approximately 400 nm and approximately 700 nm;
c) combining the radiation sources so that the radiation of each source is coincident;
d) passing the coincident radiation through at least one optical fiber;
e) providing a wand connected to the at least one optical fiber that includes an adjustably focusable collimator;
f) arranging the wand such that the radiation emitted from the wand passes through a region located within the tissue; and
g) exposing the tissue to the laser radiation for a therapeutically effective period of time.
15. The method according to claim 14 , further comprising the step of:
h) adjusting the collimator to focus the emitted radiation upon the surface of the irradiated tissue; and
i) adjusting the collimator to vary the size of the treatment area of the tissue.
16. The method for the treatment of tissue of claim 14 , wherein the treatment and aiming radiation sources incorporate light emitting diode lasers.
17. The method for the treatment of tissue of claim 14 , wherein the treatment radiation source emits radiation having a wavelength of approximately 980 nm.
18. The method for the treatment of tissue of claim 14 , wherein the aiming radiation source emits radiation having a wavelength of between approximately 635 nm and approximately 640 nm.
19. The method for the treatment of tissue of claim 14 , wherein at least one of the wands incorporates an adjustable collimator operative to vary the focus of the emitted radiation beam.
20. The method for the treatment of tissue of claim 14 , wherein the treatment radiation source is configured to emit adjustably pulsed radiation wherein the pulses have a frequency of between approximately 0.1 cycles per second and approximately 100 cycles per second.
21. The method for the treatment of tissue of claim 14 , wherein the treatment radiation source is configured to emit continuous wave radiation.
22. The method for the treatment of tissue of claim 14 , wherein the treatment radiation source is configured to adjustably emit pulsed radiation wherein the pulse width is between approximately 0.1 percent and 100 percent.
23. The method for the treatment of tissue of claim 14 , wherein the treatment radiation source is configured to adjust the power level of the emitted radiation to have a power of between about zero and approximately 2.0 watts.
24. The method for the treatment of tissue of claim 23 , wherein the treatment radiation source is configured to adjust the duration of the therapeutic laser radiation treatment to between approximately 1 second and 3600 seconds.
25. The method for the treatment of tissue of claim 14 , wherein the treatment radiation source is configured to adjust the energy level of the emitted radiation to have an energy of between approximately 1 joule and approximately 99 joules.
26. The method for the treatment of tissue of claim 25 , wherein the treatment radiation source is configured to adjust the duration of the therapeutic laser radiation treatment to between approximately 1 second and 3600 seconds.
27. A system for photobiostimulation of biological tissue, comprising:
a) a controller unit including a power supply and a control panel having operator input devices and output devices;
b) the controller unit also including a first treatment radiation source emitting a first radiation beam having a wavelength of between approximately 900 nm and approximately 1100 nm;
c) the controller unit also including an aiming radiation source emitting a second radiation beam having a wavelength of between approximately 400 nm and approximately 700 nm; wherein the first radiation beam and the second radiation beam concurrently pass through at least one of a plurality of fiber optic cables; and
d) a wand connected to the at least one of the plurality of fiber optic cables, the wand including a variably adjustable collimator configured to adjust the emanating coincident radiation beams; wherein the wands are adapted to be arranged in an operative position about the tissue to irradiate a region of the tissue.
28. A device for photobiostimulation of biological tissue, comprising:
a) a first treatment radiation source emitting a first radiation beam having a wavelength of between approximately 900 nm and approximately 1100 nm;
b) a second aiming radiation source emitting a second radiation beam having a wavelength of between approximately 400 nm and approximately 700 nm; wherein the first beam and the second beam concurrently pass through at least one of a plurality of fiber optic cables; and
c) a wand connected to the at least one of the plurality of fiber optic cables, the wand including a collimator configured to adjust the shape of the emanating radiation beam;
wherein the wand is adapted to be arranged in an operative position about the tissue to irradiate a region of the tissue.
29. A device for photobiostimulation of biological tissue, comprising:
a) a treatment radiation source emitting a respective first radiation beam having a wavelength of between approximately 900 nm and approximately 1100 nm;
b) a second aiming radiation source emitting a respective second radiation beam having a wavelength of between approximately 400 nm and approximately 700 nm; wherein the first beam and second beam concurrently pass through a fiber optic cable; and
c) a wand connected to the fiber optic cable, and including a collimator configured to adjust the focus of the emanating radiation beam;
wherein the wand is adapted to be arranged in an operative position about the tissue such that the radiation beam emitted from the wand illuminates a region located in the tissue.
30. A device for photobiostimulation of biological tissue, comprising:
a) a first treatment radiation source emitting a first radiation beam having a wavelength of between approximately 900 nm and approximately 1100 nm;
b) a second radiation source emitting a second radiation beam having a wavelength of between approximately 400 nm and approximately 700 nm; wherein at least one first beam and one second beam concurrently pass through at least two of a plurality of fiber optic cables; and
c) at least two wands each connected to a different one of the plurality of fiber optic cables, the wands including a variable collimator configured to establish the focus of the emanating coincident radiation beams;
wherein the wands are adapted to be arranged in an operative position about the tissue such that the radiation beams emitted from each wand simultaneously pass approximately through a region located in the tissue.
31. The biostimulation device of claim 30 , wherein the treatment and aiming radiation sources incorporate light emitting diode lasers.
32. The biostimulation device of claim 30 , wherein the treatment radiation source emits radiation having a wavelength of approximately 980 nm.
33. The biostimulation device of claim 30 , wherein the aiming radiation source emits radiation having a wavelength of between approximately 635 nm and approximately 640 nm.
34. The biostimulation device of claim 30 , wherein at least one of the wands incorporates an adjustable collimator operative to vary the focus of the emitted radiation beam.
35. The biostimulation device of claim 30 , wherein the treatment radiation source is configured to emit adjustably pulsed radiation wherein the pulses have a frequency of between approximately 0.1 cycles per second and approximately 100 cycles per second.
36. The biostimulation device of claim 30 , wherein the treatment radiation source is configured to emit continuous wave radiation.
37. The biostimulation device of claim 30 , wherein the treatment radiation source is configured to adjustably emit pulsed radiation wherein the pulse width is between approximately 0.1 percent and 100 percent.
38. The biostimulation device of claim 30 , wherein the treatment radiation source is configured to adjust the power level of the emitted radiation to have a power of between zero and approximately 2.0 watts.
39. The biostimulation device of claim 38 , wherein the treatment radiation source is configured to adjust the duration of the therapeutic laser radiation treatment to between approximately 1 second and 3600 seconds.
40. The biostimulation device of claim 30 , wherein the treatment radiation source is configured to adjust the energy level of the emitted radiation to have a power of between approximately 1 joule and 99 joules.
41. The biostimulation device of claim 40 , wherein the treatment radiation source is configured to adjust the duration of the therapeutic laser radiation treatment to between approximately 1 second and 3600 seconds.
42. A method for the treatment of tissue, comprising the steps of:
a) providing at least one infrared laser treatment radiation source having a wavelength of between approximately 900 nm and approximately 1100 nm;
b) providing at least one source of aiming laser radiation having a wavelength of between approximately 400 nm and approximately 700 nm;
c) combining the radiation sources so that the radiation of each source is coincident;
d) passing the coincident radiation through at least two optical fibers;
e) providing at least two wands, each connected to a different one of the at least two optical fibers, the wands each including a variably focusable collimator;
f) arranging the wands such that the radiation emitted from the wands simultaneously passes through a region located within the tissue; and
g) exposing the tissue to the laser radiation for a therapeutically effective period of time.
43. The method for the treatment of tissue of claim 42 , wherein the treatment and aiming radiation sources incorporate light emitting diode lasers.
44. The method for the treatment of tissue of claim 42 , wherein the treatment radiation source emits radiation having a wavelength of approximately 980 nm.
45. The method for the treatment of tissue of claim 42 , wherein the aiming radiation source emits radiation having a wavelength of between approximately 635 nm and approximately 640 nm.
46. The method for the treatment of tissue of claim 42 , wherein at least one of the wands incorporates an adjustable collimator operative to vary the focus of the emitted radiation beam.
47. The method for the treatment of tissue of claim 42 , wherein the treatment radiation source is configured to emit adjustably pulsed radiation wherein the pulses have a frequency of between approximately 0.1 cycles per second and approximately 100 cycles per second.
48. The method for the treatment of tissue of claim 42 , wherein the treatment radiation source is configured to emit continuous wave radiation.
49. The method for the treatment of tissue of claim 42 , wherein the treatment radiation source is configured to adjustably emit pulsed radiation wherein the pulse width is between approximately 0.1 percent and 100 percent.
50. The method for the treatment of tissue of claim 42 , wherein the treatment radiation source is configured to adjust the power level of the emitted radiation to have a power of between zero and approximately 2.0 watts.
51. The method for the treatment of tissue of claim 50 , wherein the treatment radiation source is configured to adjust the duration of the therapeutic laser radiation treatment to between approximately 1 second and 3600 seconds.
52. The method for the treatment of tissue of claim 42 , wherein the treatment radiation source is configured to adjust the energy level of the emitted radiation to have a power of between approximately 1 joule and 99 joules.
53. The method for the treatment of tissue of claim 52 , wherein the treatment radiation source is configured to adjust the duration of the therapeutic laser radiation treatment to between approximately 1 second and 3600 seconds.
54. A system for photobiostimulation of biological tissue, comprising:
a) a controller unit including a power supply and a control panel having operator input devices and output devices;
b) the controller unit also including a first treatment radiation source emitting a first radiation beam having a wavelength of between approximately 900 nm and approximately 1100 nm;
c) the controller unit also including a second aiming radiation source emitting a second radiation beam having a wavelength of between approximately 400 nm and approximately 700 nm; wherein the first radiation beam and the second radiation beam concurrently pass through at least two of a plurality of fiber optic cables; and
d) at least two wands each connected to a different one of the plurality of fiber optic cables, the wands including a variably adjustable collimator configured to establish the shape and focus of the emanating coincident radiation beams; wherein the wands are adapted to be arranged in an operative position about the tissue such that the radiation beams emitted from each wand simultaneously pass approximately through a region located in the tissue.
55. A device for photobiostimulation of biological tissue, comprising:
a) a first treatment radiation source emitting a first radiation beam having a wavelength of between approximately 900 nm and approximately 1100 nm;
b) a second radiation source emitting a second radiation beam having a wavelength of between approximately 400 nm and approximately 700 nm; wherein the first beam and the second beam concurrently pass through at least two of a plurality of fiber optic cables; and
c) at least two wands each connected to a different one of the plurality of fiber optic cables, at least one of the wands including a collimator configured to adjust the shape of the emanating radiation beam;
wherein the wands are adapted to be arranged in an operative position about the tissue such that the radiation beams emitted from each wand simultaneously pass approximately through a region located in the tissue.
56. A system for photobiostimulation of biological tissue, comprising:
a) a controller unit including a power supply and a control panel having operator input devices and output devices;
b) the controller unit also including a first treatment radiation source emitting a first radiation beam having a wavelength of between approximately 900 nm and approximately 1100 nm;
c) the controller unit also including a second aiming radiation source emitting a second radiation beam having a wavelength of between approximately 400 nm and approximately 700 nm; wherein the first radiation beam and the second radiation beam concurrently pass through at least two of a plurality of fiber optic cables; and
d) at least two wands each connected to a different one of the plurality of fiber optic cables, the wands including a variably adjustable collimator; wherein the wands are adapted to be arranged in an operative position about the tissue such that the radiation beams emitted from each wand simultaneously pass approximately through a region located in the tissue.
57. A method for the treatment of tissue, comprising the steps of:
a) providing at least one infrared laser treatment radiation source having a wavelength of between approximately 900 nm and approximately 1100 nm;
b) providing at least one source of aiming laser radiation having a wavelength of between approximately 400 nm and approximately 700 nm;
c) combining the radiation sources so that the radiation of each source is coincident;
d) passing the coincident radiation through at least two optical fibers;
e) providing at least two wands, connected to the optical fibers, wherein at least one wand includes a variably adjustable collimator;
f) arranging the wands such that the radiation emitted from the wands simultaneously passes through a region located within the tissue; and
g) exposing the tissue to the laser radiation for a therapeutically effective period of time.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/847,235 US20020002391A1 (en) | 1999-03-29 | 2001-05-02 | Method and apparatus for therapeutic laser treatment |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/281,443 US6267779B1 (en) | 1999-03-29 | 1999-03-29 | Method and apparatus for therapeutic laser treatment |
US09/847,235 US20020002391A1 (en) | 1999-03-29 | 2001-05-02 | Method and apparatus for therapeutic laser treatment |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/281,443 Continuation US6267779B1 (en) | 1999-03-29 | 1999-03-29 | Method and apparatus for therapeutic laser treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020002391A1 true US20020002391A1 (en) | 2002-01-03 |
Family
ID=23077318
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/281,443 Expired - Fee Related US6267779B1 (en) | 1999-03-29 | 1999-03-29 | Method and apparatus for therapeutic laser treatment |
US09/847,235 Abandoned US20020002391A1 (en) | 1999-03-29 | 2001-05-02 | Method and apparatus for therapeutic laser treatment |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/281,443 Expired - Fee Related US6267779B1 (en) | 1999-03-29 | 1999-03-29 | Method and apparatus for therapeutic laser treatment |
Country Status (11)
Country | Link |
---|---|
US (2) | US6267779B1 (en) |
EP (1) | EP1244391A1 (en) |
KR (1) | KR20010090805A (en) |
AU (1) | AU3926600A (en) |
BR (1) | BR0007022A (en) |
CA (1) | CA2359807A1 (en) |
DE (1) | DE10084417T1 (en) |
GB (1) | GB2361646A (en) |
HU (1) | HUP0301300A2 (en) |
MX (1) | MXPA01004154A (en) |
WO (1) | WO2000057804A1 (en) |
Cited By (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040236267A1 (en) * | 2003-02-28 | 2004-11-25 | Advanced Light Technology, Llc, A Corporation Of The State Of California | Disinfection, destruction of neoplastic growth, and sterilization by differential absorption of electromagnetic energy |
US20050013341A1 (en) * | 2003-07-14 | 2005-01-20 | Shahin Baghai | Laser brightness |
US20050027336A1 (en) * | 2003-03-03 | 2005-02-03 | Mikhail Nemenov | Portable laser and process for producing controlled pain |
US20050090877A1 (en) * | 1999-07-07 | 2005-04-28 | Yoram Harth | Phototherapeutic treatment of skin conditions |
US20050131499A1 (en) * | 2001-03-02 | 2005-06-16 | Shanks Steven C. | Laser device to treat sympathetic and parasympathetic nervous systems |
US20060009823A1 (en) * | 2004-07-08 | 2006-01-12 | Richardson Brian D | Luminex® laser therapy system |
US20060161227A1 (en) * | 2004-11-12 | 2006-07-20 | Northwestern University | Apparatus and methods for optical stimulation of the auditory nerve |
US20060206176A1 (en) * | 2001-03-02 | 2006-09-14 | Shanks Steven C | Method of using multi-probe laser device |
US20070060984A1 (en) * | 2005-09-09 | 2007-03-15 | Webb James S | Apparatus and method for optical stimulation of nerves and other animal tissue |
US7198633B1 (en) * | 2003-07-15 | 2007-04-03 | Darren Starwynn | Light/electric probe system and method |
US20070106284A1 (en) * | 2001-08-23 | 2007-05-10 | Jerry Siegel | Apparatus and method for performing radiation energy treatments |
US20070162093A1 (en) * | 2006-01-11 | 2007-07-12 | Porter Roger D | Therapeutic laser treatment |
US20070179480A1 (en) * | 2004-06-21 | 2007-08-02 | Doron Nevo | Dermatological laser system |
US20070255359A1 (en) * | 2006-04-20 | 2007-11-01 | Joseph Neev | Skin treatment and hair treatment device with protruding guards |
US20070271714A1 (en) * | 2006-03-17 | 2007-11-29 | Light Dimensions, Inc. | Light-based enhancing apparatuses and methods of use |
US20080077198A1 (en) * | 2006-09-21 | 2008-03-27 | Aculight Corporation | Miniature apparatus and method for optical stimulation of nerves and other animal tissue |
US7373254B2 (en) | 2001-05-03 | 2008-05-13 | Advanced Light Technology, Llc | Disinfestation of medical implants with radiation |
US20080177359A1 (en) * | 2002-05-03 | 2008-07-24 | Advanced Light Technology, Llc. | Differential photochemical and photomechanical processing |
US20080206420A1 (en) * | 2002-07-05 | 2008-08-28 | Mcfadden David H | Air Fryer |
US20080269847A1 (en) * | 2004-03-02 | 2008-10-30 | Mikhall Nemenov | Portable laser and process for pain research |
US20090088822A1 (en) * | 2007-09-27 | 2009-04-02 | Led Healing Light, Llc | Therapeutic pulse laser methods and apparatus |
US20100241038A1 (en) * | 2009-03-20 | 2010-09-23 | Bwt Property, Inc. | Phototherapy Method for Assisting Transvenous Lead Placement |
US20100292758A1 (en) * | 2009-01-23 | 2010-11-18 | Lockheed Martin Corporation | Optical stimulation of the brainstem and/or midbrain, including auditory areas |
US20100331930A1 (en) * | 2005-04-01 | 2010-12-30 | Burgmann Thomas A D | Phototherapy device |
US7883536B1 (en) | 2007-01-19 | 2011-02-08 | Lockheed Martin Corporation | Hybrid optical-electrical probes |
US20110040295A1 (en) * | 2003-02-28 | 2011-02-17 | Photometics, Inc. | Cancer treatment using selective photo-apoptosis |
WO2011081363A2 (en) * | 2009-12-31 | 2011-07-07 | 오우메드 주식회사 | Therapy apparatus comprising a laser-emitting unit for electrically stimulating acupuncture points |
US20110172746A1 (en) * | 2010-01-12 | 2011-07-14 | Roger Porter | High Level Laser Therapy Apparatus and Methods |
US8012189B1 (en) | 2007-01-11 | 2011-09-06 | Lockheed Martin Corporation | Method and vestibular implant using optical stimulation of nerves |
WO2011150430A3 (en) * | 2010-05-28 | 2012-02-23 | Lockheed Martin Corporation | Implantable infrared nerve stimulation devices for peripheral and cranial nerve interfaces |
US8160696B2 (en) | 2008-10-03 | 2012-04-17 | Lockheed Martin Corporation | Nerve stimulator and method using simultaneous electrical and optical signals |
US20120150263A1 (en) * | 2001-03-02 | 2012-06-14 | Erchonia Corporation | Fungal Infection Therapy Method with Low Level Laser |
US8475506B1 (en) | 2007-08-13 | 2013-07-02 | Lockheed Martin Corporation | VCSEL array stimulator apparatus and method for light stimulation of bodily tissues |
US8498699B2 (en) | 2008-10-03 | 2013-07-30 | Lockheed Martin Company | Method and nerve stimulator using simultaneous electrical and optical signals |
US8574280B2 (en) | 2011-12-23 | 2013-11-05 | Pine Development Corporation | Systems and methods for eliciting cutaneous sensations by electromagnetic radiation |
US8709078B1 (en) | 2011-08-03 | 2014-04-29 | Lockheed Martin Corporation | Ocular implant with substantially constant retinal spacing for transmission of nerve-stimulation light |
US8747447B2 (en) | 2011-07-22 | 2014-06-10 | Lockheed Martin Corporation | Cochlear implant and method enabling enhanced music perception |
CN103986444A (en) * | 2014-05-09 | 2014-08-13 | 健力普(北京)医疗科技有限公司 | Output control method and device for physical factors |
US8813756B1 (en) | 2004-02-06 | 2014-08-26 | Erchonia Corporation | Non-invasive method for slimming a human body using laser energy of wavelengths shorter than 632 nm |
US8929973B1 (en) | 2005-10-24 | 2015-01-06 | Lockheed Martin Corporation | Apparatus and method for characterizing optical sources used with human and animal tissues |
US8945197B1 (en) | 2005-10-24 | 2015-02-03 | Lockheed Martin Corporation | Sight-restoring visual prosthetic and method using infrared nerve-stimulation light |
US8956396B1 (en) | 2005-10-24 | 2015-02-17 | Lockheed Martin Corporation | Eye-tracking visual prosthetic and method |
US8996131B1 (en) | 2006-09-28 | 2015-03-31 | Lockheed Martin Corporation | Apparatus and method for managing chronic pain with infrared light sources and heat |
US9257021B2 (en) | 2013-04-12 | 2016-02-09 | Pine Development Corporation | Systems and methods for optically induced cutaneous sensation |
US20160066994A1 (en) * | 2014-09-09 | 2016-03-10 | Erchonia Corporation | Non-Invasive Method for Slimming a Human Body Using Two Wavelngths of Laser Energy Concurrently |
CN105682738A (en) * | 2013-10-07 | 2016-06-15 | S·约翰逊 | A method and apparatus for controlling a laser probe |
US9449477B2 (en) | 2014-04-02 | 2016-09-20 | Pine Development Corporation | Applications of systems and methods for eliciting cutaneous sensations by electromagnetic radiation |
US9696804B2 (en) | 2011-12-23 | 2017-07-04 | Pine Development Corporation | Systems and methods for eliciting cutaneous sensations by electromagnetic radiation |
US9907975B1 (en) | 2014-11-19 | 2018-03-06 | Roger D. Porter | Therapeutic laser treatment and transdermal stimulation of stem cell differentiation |
CN109557092A (en) * | 2018-11-22 | 2019-04-02 | 中国人民解放军军事科学院国防科技创新研究院 | It is a kind of for enhancing the cranial nerve stimulating apparatus of big brain cognitive function |
US10295823B2 (en) | 2013-07-02 | 2019-05-21 | Pine Development Corporation | Systems and methods for eliciting cutaneous sensations using electromagnetic radiation |
US11007373B1 (en) | 2002-12-20 | 2021-05-18 | James Andrew Ohneck | Photobiostimulation device and method of using same |
US11517373B2 (en) * | 2016-12-27 | 2022-12-06 | Alma Lasers Ltd. | Switched lasers for dermal treatment |
Families Citing this family (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6517532B1 (en) | 1997-05-15 | 2003-02-11 | Palomar Medical Technologies, Inc. | Light energy delivery head |
US6508813B1 (en) | 1996-12-02 | 2003-01-21 | Palomar Medical Technologies, Inc. | System for electromagnetic radiation dermatology and head for use therewith |
US8182473B2 (en) | 1999-01-08 | 2012-05-22 | Palomar Medical Technologies | Cooling system for a photocosmetic device |
ES2226133T3 (en) | 1997-05-15 | 2005-03-16 | Palomar Medical Technologies, Inc. | DERMATOLOGICAL TREATMENT DEVICE. |
US20060212025A1 (en) | 1998-11-30 | 2006-09-21 | Light Bioscience, Llc | Method and apparatus for acne treatment |
US6887260B1 (en) | 1998-11-30 | 2005-05-03 | Light Bioscience, Llc | Method and apparatus for acne treatment |
US9192780B2 (en) | 1998-11-30 | 2015-11-24 | L'oreal | Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders |
US6283956B1 (en) | 1998-11-30 | 2001-09-04 | David H. McDaniels | Reduction, elimination, or stimulation of hair growth |
ES1044983Y (en) * | 1999-12-28 | 2000-12-16 | Castilla Antonia Villalon | THERMOSTIMULATION APPARATUS FOR THERAPEUTIC TREATMENTS. |
US6921413B2 (en) * | 2000-08-16 | 2005-07-26 | Vanderbilt University | Methods and devices for optical stimulation of neural tissues |
RU2165743C1 (en) * | 2000-09-12 | 2001-04-27 | Хомченко Владимир Валентинович | Method for performing blood vessel laser coagulation |
JP4022040B2 (en) * | 2000-10-05 | 2007-12-12 | 松下電器産業株式会社 | Semiconductor device |
US6746444B2 (en) * | 2000-12-18 | 2004-06-08 | Douglas J. Key | Method of amplifying a beneficial selective skin response to light energy |
DK200100153A (en) * | 2001-01-30 | 2002-07-31 | Unilaser As | Apparatus for stimulating and activating cell function in living tissue |
US7947067B2 (en) * | 2004-02-04 | 2011-05-24 | Erchonia Corporation | Scanning treatment laser with sweep beam spot and universal carriage |
US20060229690A1 (en) * | 2001-03-02 | 2006-10-12 | Shanks Steven C | Device that emits laser beams at automatically-changing pulse frequencies |
US8439959B2 (en) * | 2004-10-29 | 2013-05-14 | Erchonia Corporation | Full-body laser scanner and method of mapping and contouring the body |
US7922751B2 (en) * | 2004-02-04 | 2011-04-12 | Erchonia Corporation | Stand-alone scanning laser device |
US6746473B2 (en) * | 2001-03-02 | 2004-06-08 | Erchonia Patent Holdings, Llc | Therapeutic laser device |
US20100016931A1 (en) * | 2001-03-02 | 2010-01-21 | Therapy Products, Inc. | Method of Reducing Cholesterol Using Laser Energy |
EP1414516A2 (en) * | 2001-06-26 | 2004-05-06 | Photomed Technologies, Inc. | Therapeutic methods using electromagnetic radiation |
US20040158300A1 (en) * | 2001-06-26 | 2004-08-12 | Allan Gardiner | Multiple wavelength illuminator having multiple clocked sources |
US7303578B2 (en) | 2001-11-01 | 2007-12-04 | Photothera, Inc. | Device and method for providing phototherapy to the brain |
US7329274B2 (en) * | 2001-11-29 | 2008-02-12 | Palomar Medical Technologies, Inc. | Conforming oral phototherapy applicator |
US7177695B2 (en) | 2001-12-17 | 2007-02-13 | Cefamoptec Industries, Inc. | Early stage wound healing using electromagnetic radiation |
US10695577B2 (en) | 2001-12-21 | 2020-06-30 | Photothera, Inc. | Device and method for providing phototherapy to the heart |
US6758844B2 (en) * | 2002-01-24 | 2004-07-06 | Ceramoptec Industries, Inc. | System and method for oral treatments |
WO2004000098A2 (en) | 2002-06-19 | 2003-12-31 | Palomar Medical Technologies, Inc. | Method and apparatus for treatment of cutaneous and subcutaneous conditions |
US7084389B2 (en) * | 2002-09-11 | 2006-08-01 | Donald Spector | Hand held led device |
JP2006501960A (en) * | 2002-10-07 | 2006-01-19 | パロマー・メディカル・テクノロジーズ・インコーポレイテッド | Apparatus for photobiological stimulation |
AU2003284972B2 (en) | 2002-10-23 | 2009-09-10 | Palomar Medical Technologies, Inc. | Phototreatment device for use with coolants and topical substances |
KR20060041161A (en) * | 2003-04-10 | 2006-05-11 | 라이트 바이오사이언스, 엘엘씨 | Photomodulation methods and devices for regulating cell proliferation and gene expression |
US20040210277A1 (en) * | 2003-04-16 | 2004-10-21 | Hans Becker | Laser and light emitting diode body irradiator method and apparatus |
JP4739202B2 (en) * | 2003-07-31 | 2011-08-03 | ジェントルウェイブス エルエルシー | System and method for photodynamic treatment of burns, wounds, and related skin diseases |
US20050065577A1 (en) * | 2003-09-23 | 2005-03-24 | Mcarthur Frank G. | Low level laser tissue treatment |
DE10353263A1 (en) * | 2003-11-14 | 2005-06-23 | Teichert, Klaus, Dr. med. | Irradiation device and its use |
US7220254B2 (en) * | 2003-12-31 | 2007-05-22 | Palomar Medical Technologies, Inc. | Dermatological treatment with visualization |
US20050167438A1 (en) * | 2004-02-02 | 2005-08-04 | Max Minyayev | Secure spill-proof configuration for child training cup |
US20070135870A1 (en) * | 2004-02-04 | 2007-06-14 | Hearingmed Laser Technologies, Llc | Method for treating hearing loss |
AU2005231443B2 (en) | 2004-04-01 | 2012-02-23 | The General Hospital Corporation | Method and apparatus for dermatological treatment and tissue reshaping |
EP1755741A4 (en) * | 2004-04-13 | 2009-07-15 | Adrianna Scheibner | Laser treatment |
US20050245998A1 (en) * | 2004-04-30 | 2005-11-03 | Led Healing Light, Llc | Hand held pulse laser for therapeutic use |
US7686839B2 (en) * | 2005-01-26 | 2010-03-30 | Lumitex, Inc. | Phototherapy treatment devices for applying area lighting to a wound |
US20060229689A1 (en) * | 2005-04-08 | 2006-10-12 | Led Technologies, Llc | LED therapy device |
US7856985B2 (en) | 2005-04-22 | 2010-12-28 | Cynosure, Inc. | Method of treatment body tissue using a non-uniform laser beam |
JP2009509140A (en) | 2005-09-15 | 2009-03-05 | パロマー・メデイカル・テクノロジーズ・インコーポレーテツド | Skin optical determination device |
US7575589B2 (en) * | 2006-01-30 | 2009-08-18 | Photothera, Inc. | Light-emitting device and method for providing phototherapy to the brain |
US20070282400A1 (en) * | 2006-06-02 | 2007-12-06 | Kendall Jay Gorham | Combination medical therapy device that integrates: electrical stimulation, light therapy, heat, pressure, and vibration |
EP2043544A4 (en) * | 2006-07-13 | 2010-12-15 | Reliant Technologies Llc | Apparatus and method for adjustable fractional optical dermatological treatment |
US20080033412A1 (en) * | 2006-08-01 | 2008-02-07 | Harry Thomas Whelan | System and method for convergent light therapy having controllable dosimetry |
US7586957B2 (en) | 2006-08-02 | 2009-09-08 | Cynosure, Inc | Picosecond laser apparatus and methods for its operation and use |
US20080147150A1 (en) * | 2006-12-19 | 2008-06-19 | Zhenhong Xiong | Medical laser device |
US8202268B1 (en) | 2007-03-18 | 2012-06-19 | Lockheed Martin Corporation | Method and multiple-mode device for high-power short-pulse laser ablation and CW cauterization of bodily tissues |
US9486286B2 (en) | 2007-05-14 | 2016-11-08 | Boston Scientific Scimed, Inc. | Medical laser user interface |
EP2166921A4 (en) * | 2007-06-15 | 2010-07-07 | Max Endoscopy Inc | Flexible infrared delivery apparatus and method |
US9079022B2 (en) | 2007-09-27 | 2015-07-14 | Led Intellectual Properties, Llc | LED based phototherapy device for photo-rejuvenation of cells |
WO2009088550A2 (en) * | 2007-10-19 | 2009-07-16 | Lockheed Martin Corporation | System and method for conditioning animal tissue using laser light |
US20090132012A1 (en) * | 2007-11-16 | 2009-05-21 | Therapy Products, Inc. | Method for pretreating patient before surgery |
US20100016732A1 (en) * | 2008-07-17 | 2010-01-21 | Lockheed Martin Corporation | Apparatus and method for neural-signal capture to drive neuroprostheses or control bodily function |
US7848035B2 (en) | 2008-09-18 | 2010-12-07 | Photothera, Inc. | Single-use lens assembly |
US20110190749A1 (en) | 2008-11-24 | 2011-08-04 | Mcmillan Kathleen | Low Profile Apparatus and Method for Phototherapy |
CN102281917A (en) * | 2008-11-24 | 2011-12-14 | 格雷迪安特研究有限责任公司 | Photothermal treatment of soft tissues |
US9149647B2 (en) * | 2008-12-14 | 2015-10-06 | C Laser, Inc. | Method for deep tissue laser treatments using low intensity laser therapy causing selective destruction of Nociceptive nerves |
US9693825B2 (en) * | 2008-12-14 | 2017-07-04 | C Laser, Inc. | Fiber embedded hollow needle for percutaneous delivery of laser energy |
US20100196497A1 (en) * | 2009-02-02 | 2010-08-05 | Therapy Products, Inc. | Method of Treating Tissue Using Platelet-Rich Plasma in Combination with Low-Level Laser Therapy |
US9919168B2 (en) | 2009-07-23 | 2018-03-20 | Palomar Medical Technologies, Inc. | Method for improvement of cellulite appearance |
US8790382B2 (en) * | 2009-08-04 | 2014-07-29 | Yonatan Gerlitz | Handheld low-level laser therapy apparatus |
US9553422B2 (en) | 2009-08-04 | 2017-01-24 | Medical Coherence Llc | Multiple aperture hand-held laser therapy apparatus |
EP2477570A4 (en) * | 2009-09-15 | 2013-04-03 | Ceramoptec Gmbh | Ablative/coagulative urological treatment device and method |
US8608786B2 (en) * | 2009-09-18 | 2013-12-17 | Dror Irge | Apparatus for delivering multiple forms of electromagnetic radiation and method for its use |
US8845626B2 (en) * | 2009-10-01 | 2014-09-30 | Coherent, Inc. | Lensed dual-chip fiber-coupler for providing an aiming beam in an infrared radiation delivery apparatus |
US8652534B2 (en) * | 2009-10-14 | 2014-02-18 | Berry Pharmaceuticals, LLC | Compositions and methods for treatment of mammalian skin |
US9265576B2 (en) * | 2010-02-21 | 2016-02-23 | C Laser, Inc. | Laser generator for medical treatment |
US9044594B2 (en) * | 2010-02-21 | 2015-06-02 | C Laser, Inc. | Laser generator for deep tissue laser treatments using low intensity laser therapy causing selective destruction of nociceptive nerves |
US10206742B2 (en) | 2010-02-21 | 2019-02-19 | C Laser, Inc. | Fiber embedded hollow spikes for percutaneous delivery of laser energy |
US8518094B2 (en) * | 2010-03-02 | 2013-08-27 | Bwt Property, Inc. | Precisely guided phototherapy apparatus |
WO2012048241A2 (en) | 2010-10-07 | 2012-04-12 | Gradiant Research, Llc | Method and apparatus for skin cancer thermal therapy |
WO2012176071A2 (en) | 2011-05-13 | 2012-12-27 | Bactriblue, Ltd. | Methods and apparatus for reducing count of infectious agents in intravenous access systems |
US9606003B2 (en) | 2012-03-28 | 2017-03-28 | Yonatan Gerlitz | Clinical hand-held infrared thermometer with special optical configuration |
KR102342629B1 (en) | 2012-04-18 | 2021-12-22 | 싸이노슈어, 엘엘씨 | Picosecond laser apparatus and methods for treating target tissues with same |
US10589120B1 (en) * | 2012-12-31 | 2020-03-17 | Gary John Bellinger | High-intensity laser therapy method and apparatus |
US10285757B2 (en) | 2013-03-15 | 2019-05-14 | Cynosure, Llc | Picosecond optical radiation systems and methods of use |
US9946082B2 (en) | 2013-04-30 | 2018-04-17 | Medical Coherence Llc | Handheld, low-level laser apparatuses and methods for low-level laser beam production |
KR102069603B1 (en) * | 2017-11-13 | 2020-02-11 | 재단법인 대구경북첨단의료산업진흥재단 | System and method for producing localized photo-thrombosis animal model |
KR102627248B1 (en) | 2018-02-26 | 2024-01-19 | 싸이노슈어, 엘엘씨 | Q-switched cavity dumping subnanosecond laser |
US11280096B1 (en) * | 2018-10-31 | 2022-03-22 | Harry Bussey | Cushioning preform for flooring |
US10939517B2 (en) | 2019-05-15 | 2021-03-02 | SABER Corporation | Feedback control of light emitting devices using fluorescent components and light sensors |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3769963A (en) | 1972-03-31 | 1973-11-06 | L Goldman | Instrument for performing laser micro-surgery and diagnostic transillumination of living human tissue |
US3900034A (en) | 1974-04-10 | 1975-08-19 | Us Energy | Photochemical stimulation of nerves |
US4069823A (en) | 1976-04-19 | 1978-01-24 | Viktor Leonidovich Isakov | Apparatus for laser therapy |
US4396285A (en) | 1980-08-25 | 1983-08-02 | Coherent, Inc. | Laser system and its method of use |
JPS5886787A (en) | 1981-11-19 | 1983-05-24 | Nippon Sekigaisen Kogyo Kk | Laser emitting device |
US4699839A (en) | 1982-10-27 | 1987-10-13 | Sermetel Corp. | Coated part, coating therefor and method of forming same |
US4573467A (en) | 1983-05-13 | 1986-03-04 | The United States Of America As Represented By The Department Of Health And Human Services | Optical coupling device for biomicroscope |
US4669839A (en) | 1983-09-16 | 1987-06-02 | Carl-Zeiss-Stiftung | Optical system for therapeutic use of laser light |
US5002051A (en) | 1983-10-06 | 1991-03-26 | Lasery Surgery Software, Inc. | Method for closing tissue wounds using radiative energy beams |
US4854320A (en) | 1983-10-06 | 1989-08-08 | Laser Surgery Software, Inc. | Laser healing method and apparatus |
JPS60132571A (en) | 1983-12-19 | 1985-07-15 | 澁谷工業株式会社 | Treatment of dermatophytosis |
US4724835A (en) | 1984-03-06 | 1988-02-16 | Pain Suppression Labs, Inc. | Laser therapeutic device |
JPS60232176A (en) | 1984-04-20 | 1985-11-18 | ジユデイス ウオーカー エム.デイ. | Treatment apparatus by laser beam |
US5346488A (en) | 1985-04-08 | 1994-09-13 | The General Hospital Corporation | Laser-induced ablation of atherosclerotic plaque |
US5196004A (en) | 1985-07-31 | 1993-03-23 | C. R. Bard, Inc. | Infrared laser catheter system |
JPS633873A (en) * | 1986-06-23 | 1988-01-08 | 富士電機株式会社 | Laser remedy device |
JPS63216579A (en) | 1987-03-05 | 1988-09-08 | 大工園 則雄 | Laser beam irradiation apparatus for hyperthermia |
IL82830A (en) | 1987-06-09 | 1992-03-29 | Simeone Rochkind | Apparatus for inducing functional regeneration of nerve fibres at an injured site of the spinal cord |
US5259380A (en) | 1987-11-04 | 1993-11-09 | Amcor Electronics, Ltd. | Light therapy system |
US4930504A (en) * | 1987-11-13 | 1990-06-05 | Diamantopoulos Costas A | Device for biostimulation of tissue and method for treatment of tissue |
US5112328A (en) | 1988-01-25 | 1992-05-12 | Refractive Laser Research & Development Program, Ltd. | Method and apparatus for laser surgery |
US4931053A (en) | 1988-01-27 | 1990-06-05 | L'esperance Medical Technologies, Inc. | Method and apparatus for enhanced vascular or other growth |
US5147349A (en) * | 1988-10-07 | 1992-09-15 | Spectra-Physics, Inc. | Diode laser device for photocoagulation of the retina |
EP0368512A3 (en) * | 1988-11-10 | 1990-08-08 | Premier Laser Systems, Inc. | Multiwavelength medical laser system |
US5021452A (en) | 1989-01-09 | 1991-06-04 | The Board Of Regents Of The University Of Washington | Process for enhancing wound healing |
US5161526A (en) | 1989-04-04 | 1992-11-10 | Hellwing Isak A | Method of treating of bleeding in hemophiliacs |
IL89874A0 (en) | 1989-04-06 | 1989-12-15 | Nissim Nejat Danon | Apparatus for computerized laser surgery |
US4984242A (en) | 1989-09-18 | 1991-01-08 | Spectra Diode Laboratories, Inc. | GaAs/AlGaAs heterostructure laser containing indium |
GB2242307B (en) | 1990-02-09 | 1994-09-07 | Omega Universal Tech Ltd | Laser probe for biomodulation of tissue nerve and immune systems |
US5312396A (en) | 1990-09-06 | 1994-05-17 | Massachusetts Institute Of Technology | Pulsed laser system for the surgical removal of tissue |
US5445146A (en) | 1995-03-31 | 1995-08-29 | Bellinger; Gary J. | Biological tissue stimulation by low level optical energy |
US5951596A (en) | 1991-07-01 | 1999-09-14 | Laser Biotherapy Inc | Biological tissue stimulation by optical energy |
US5217455A (en) | 1991-08-12 | 1993-06-08 | Tan Oon T | Laser treatment method for removing pigmentations, lesions, and abnormalities from the skin of a living human |
WO1993021993A1 (en) | 1992-04-24 | 1993-11-11 | Kim Robin Segal | Low level laser for soft tissue treatment |
US5755752A (en) | 1992-04-24 | 1998-05-26 | Segal; Kim Robin | Diode laser irradiation system for biological tissue stimulation |
US5520679A (en) | 1992-12-03 | 1996-05-28 | Lasersight, Inc. | Ophthalmic surgery method using non-contact scanning laser |
US5707403A (en) | 1993-02-24 | 1998-01-13 | Star Medical Technologies, Inc. | Method for the laser treatment of subsurface blood vessels |
US5527350A (en) | 1993-02-24 | 1996-06-18 | Star Medical Technologies, Inc. | Pulsed infrared laser treatment of psoriasis |
US5616140A (en) | 1994-03-21 | 1997-04-01 | Prescott; Marvin | Method and apparatus for therapeutic laser treatment |
US5464436A (en) | 1994-04-28 | 1995-11-07 | Lasermedics, Inc. | Method of performing laser therapy |
US5993442A (en) * | 1997-03-25 | 1999-11-30 | Termuno Kabushiki Kaisha | Medical laser irradiation apparatus |
-
1999
- 1999-03-29 US US09/281,443 patent/US6267779B1/en not_active Expired - Fee Related
-
2000
- 2000-03-28 BR BR0007022-0A patent/BR0007022A/en not_active IP Right Cessation
- 2000-03-28 GB GB0111600A patent/GB2361646A/en not_active Withdrawn
- 2000-03-28 HU HU0301300A patent/HUP0301300A2/en unknown
- 2000-03-28 KR KR1020017005387A patent/KR20010090805A/en not_active Application Discontinuation
- 2000-03-28 DE DE10084417T patent/DE10084417T1/en not_active Withdrawn
- 2000-03-28 CA CA002359807A patent/CA2359807A1/en not_active Abandoned
- 2000-03-28 WO PCT/US2000/008136 patent/WO2000057804A1/en not_active Application Discontinuation
- 2000-03-28 EP EP00918463A patent/EP1244391A1/en not_active Withdrawn
- 2000-03-28 MX MXPA01004154A patent/MXPA01004154A/en unknown
- 2000-03-28 AU AU39266/00A patent/AU3926600A/en not_active Abandoned
-
2001
- 2001-05-02 US US09/847,235 patent/US20020002391A1/en not_active Abandoned
Cited By (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7198634B2 (en) * | 1999-07-07 | 2007-04-03 | Curelight Ltd. | Phototherapeutic treatment of skin conditions |
US20050090877A1 (en) * | 1999-07-07 | 2005-04-28 | Yoram Harth | Phototherapeutic treatment of skin conditions |
US8439927B2 (en) | 2001-03-02 | 2013-05-14 | Erchonia Corporation | Method of using a multi-probe laser device |
US20120150263A1 (en) * | 2001-03-02 | 2012-06-14 | Erchonia Corporation | Fungal Infection Therapy Method with Low Level Laser |
US20050131499A1 (en) * | 2001-03-02 | 2005-06-16 | Shanks Steven C. | Laser device to treat sympathetic and parasympathetic nervous systems |
US8083785B2 (en) | 2001-03-02 | 2011-12-27 | Erchonia Corporation | Multi-probe laser device |
US8409264B2 (en) * | 2001-03-02 | 2013-04-02 | Erchonia Corporation | Fungal infection therapy method with low level laser |
US20060206176A1 (en) * | 2001-03-02 | 2006-09-14 | Shanks Steven C | Method of using multi-probe laser device |
US7373254B2 (en) | 2001-05-03 | 2008-05-13 | Advanced Light Technology, Llc | Disinfestation of medical implants with radiation |
US8287524B2 (en) * | 2001-08-23 | 2012-10-16 | Jerry Siegel | Apparatus and method for performing radiation energy treatments |
US20070106284A1 (en) * | 2001-08-23 | 2007-05-10 | Jerry Siegel | Apparatus and method for performing radiation energy treatments |
US20080177359A1 (en) * | 2002-05-03 | 2008-07-24 | Advanced Light Technology, Llc. | Differential photochemical and photomechanical processing |
US20080206420A1 (en) * | 2002-07-05 | 2008-08-28 | Mcfadden David H | Air Fryer |
US11007373B1 (en) | 2002-12-20 | 2021-05-18 | James Andrew Ohneck | Photobiostimulation device and method of using same |
US20040236267A1 (en) * | 2003-02-28 | 2004-11-25 | Advanced Light Technology, Llc, A Corporation Of The State Of California | Disinfection, destruction of neoplastic growth, and sterilization by differential absorption of electromagnetic energy |
US7354433B2 (en) | 2003-02-28 | 2008-04-08 | Advanced Light Technologies, Llc | Disinfection, destruction of neoplastic growth, and sterilization by differential absorption of electromagnetic energy |
US20110040295A1 (en) * | 2003-02-28 | 2011-02-17 | Photometics, Inc. | Cancer treatment using selective photo-apoptosis |
US8790381B2 (en) | 2003-02-28 | 2014-07-29 | Photometics, Inc. | Disinfection, destruction of neoplastic growth, and sterilization by differential absorption of electromagnetic energy |
US20080208294A1 (en) * | 2003-02-28 | 2008-08-28 | Advanced Light Technology, Llc | Disinfection, destruction of neoplastic growth, and sterilization by differential absorption of electromagnetic energy |
US20050027336A1 (en) * | 2003-03-03 | 2005-02-03 | Mikhail Nemenov | Portable laser and process for producing controlled pain |
US7402167B2 (en) * | 2003-03-03 | 2008-07-22 | Mikhail Nemenov | Portable laser and process for producing controlled pain |
US20050013341A1 (en) * | 2003-07-14 | 2005-01-20 | Shahin Baghai | Laser brightness |
US7198633B1 (en) * | 2003-07-15 | 2007-04-03 | Darren Starwynn | Light/electric probe system and method |
US8813756B1 (en) | 2004-02-06 | 2014-08-26 | Erchonia Corporation | Non-invasive method for slimming a human body using laser energy of wavelengths shorter than 632 nm |
US20080269847A1 (en) * | 2004-03-02 | 2008-10-30 | Mikhall Nemenov | Portable laser and process for pain research |
US8029553B2 (en) * | 2004-03-02 | 2011-10-04 | Mikhall Nemenov | Portable laser and process for pain research |
US9161815B2 (en) | 2004-06-21 | 2015-10-20 | Kilolambda Technologies Ltd. | Dermatological laser system and Method for Skin Resurfacing |
US20070179480A1 (en) * | 2004-06-21 | 2007-08-02 | Doron Nevo | Dermatological laser system |
US20060009823A1 (en) * | 2004-07-08 | 2006-01-12 | Richardson Brian D | Luminex® laser therapy system |
US20060161227A1 (en) * | 2004-11-12 | 2006-07-20 | Northwestern University | Apparatus and methods for optical stimulation of the auditory nerve |
US7833257B2 (en) * | 2004-11-12 | 2010-11-16 | Northwestern University | Apparatus and methods for optical stimulation of the auditory nerve |
US20100331930A1 (en) * | 2005-04-01 | 2010-12-30 | Burgmann Thomas A D | Phototherapy device |
US7736382B2 (en) * | 2005-09-09 | 2010-06-15 | Lockheed Martin Corporation | Apparatus for optical stimulation of nerves and other animal tissue |
US20070060984A1 (en) * | 2005-09-09 | 2007-03-15 | Webb James S | Apparatus and method for optical stimulation of nerves and other animal tissue |
US8985119B1 (en) | 2005-09-09 | 2015-03-24 | Lockheed Martin Corporation | Method and apparatus for optical stimulation of nerves and other animal tissue |
US8945197B1 (en) | 2005-10-24 | 2015-02-03 | Lockheed Martin Corporation | Sight-restoring visual prosthetic and method using infrared nerve-stimulation light |
US8956396B1 (en) | 2005-10-24 | 2015-02-17 | Lockheed Martin Corporation | Eye-tracking visual prosthetic and method |
US8929973B1 (en) | 2005-10-24 | 2015-01-06 | Lockheed Martin Corporation | Apparatus and method for characterizing optical sources used with human and animal tissues |
US8316860B1 (en) | 2006-01-11 | 2012-11-27 | Curaelase, Inc. | Therapeutic laser treatment method |
US8033284B2 (en) | 2006-01-11 | 2011-10-11 | Curaelase, Inc. | Therapeutic laser treatment |
US20070162093A1 (en) * | 2006-01-11 | 2007-07-12 | Porter Roger D | Therapeutic laser treatment |
US20070271714A1 (en) * | 2006-03-17 | 2007-11-29 | Light Dimensions, Inc. | Light-based enhancing apparatuses and methods of use |
US20070255359A1 (en) * | 2006-04-20 | 2007-11-01 | Joseph Neev | Skin treatment and hair treatment device with protruding guards |
US9067060B2 (en) * | 2006-04-20 | 2015-06-30 | Joseph Neev | Skin treatment and hair treatment device with protruding guards |
US20080077198A1 (en) * | 2006-09-21 | 2008-03-27 | Aculight Corporation | Miniature apparatus and method for optical stimulation of nerves and other animal tissue |
US7988688B2 (en) * | 2006-09-21 | 2011-08-02 | Lockheed Martin Corporation | Miniature apparatus and method for optical stimulation of nerves and other animal tissue |
US20110238141A1 (en) * | 2006-09-21 | 2011-09-29 | Lockheed Martin Corporation | Miniature method and apparatus for optical stimulation of nerves and other animal tissue |
US8506613B2 (en) * | 2006-09-21 | 2013-08-13 | Lockheed Martin Corporation | Miniature method and apparatus for optical stimulation of nerves and other animal tissue |
US8784461B2 (en) * | 2006-09-21 | 2014-07-22 | Lockheed Martin Corporation | Method and apparatus for optical stimulation of nerves and other animal tissue |
US20140052221A1 (en) * | 2006-09-21 | 2014-02-20 | Lockheed Martin Corporation | Method and apparatus for optical stimulation of nerves and other animal tissue |
US9061135B1 (en) | 2006-09-28 | 2015-06-23 | Lockheed Martin Corporation | Apparatus and method for managing chronic pain with infrared and low-level light sources |
US8996131B1 (en) | 2006-09-28 | 2015-03-31 | Lockheed Martin Corporation | Apparatus and method for managing chronic pain with infrared light sources and heat |
US8317848B1 (en) | 2007-01-11 | 2012-11-27 | Lockheed Martin Corporation | Vestibular implant and method for optical stimulation of nerves |
US8012189B1 (en) | 2007-01-11 | 2011-09-06 | Lockheed Martin Corporation | Method and vestibular implant using optical stimulation of nerves |
US8551150B1 (en) | 2007-01-11 | 2013-10-08 | Lockheed Martin Corporation | Method and system for optical stimulation of nerves |
US8357187B1 (en) | 2007-01-19 | 2013-01-22 | Lockheed Martin Corporation | Hybrid optical-electrical probes for stimulation of nerve or other animal tissue |
US8632577B1 (en) | 2007-01-19 | 2014-01-21 | Lockheed Martin Corporation | Hybrid optical-electrical probes for stimulation of nerve or other animal tissue |
US7883536B1 (en) | 2007-01-19 | 2011-02-08 | Lockheed Martin Corporation | Hybrid optical-electrical probes |
US8475506B1 (en) | 2007-08-13 | 2013-07-02 | Lockheed Martin Corporation | VCSEL array stimulator apparatus and method for light stimulation of bodily tissues |
US20090088822A1 (en) * | 2007-09-27 | 2009-04-02 | Led Healing Light, Llc | Therapeutic pulse laser methods and apparatus |
US8998914B2 (en) | 2007-11-30 | 2015-04-07 | Lockheed Martin Corporation | Optimized stimulation rate of an optically stimulating cochlear implant |
US9011509B2 (en) | 2007-11-30 | 2015-04-21 | Lockheed Martin Corporation | Individually optimized performance of optically stimulating cochlear implants |
US9011508B2 (en) | 2007-11-30 | 2015-04-21 | Lockheed Martin Corporation | Broad wavelength profile to homogenize the absorption profile in optical stimulation of nerves |
US8498699B2 (en) | 2008-10-03 | 2013-07-30 | Lockheed Martin Company | Method and nerve stimulator using simultaneous electrical and optical signals |
US8160696B2 (en) | 2008-10-03 | 2012-04-17 | Lockheed Martin Corporation | Nerve stimulator and method using simultaneous electrical and optical signals |
US8744570B2 (en) | 2009-01-23 | 2014-06-03 | Lockheed Martin Corporation | Optical stimulation of the brainstem and/or midbrain, including auditory areas |
US20100292758A1 (en) * | 2009-01-23 | 2010-11-18 | Lockheed Martin Corporation | Optical stimulation of the brainstem and/or midbrain, including auditory areas |
US20100241038A1 (en) * | 2009-03-20 | 2010-09-23 | Bwt Property, Inc. | Phototherapy Method for Assisting Transvenous Lead Placement |
WO2011081363A2 (en) * | 2009-12-31 | 2011-07-07 | 오우메드 주식회사 | Therapy apparatus comprising a laser-emitting unit for electrically stimulating acupuncture points |
WO2011081363A3 (en) * | 2009-12-31 | 2011-11-10 | 오우메드 주식회사 | Therapy apparatus comprising a laser-emitting unit for electrically stimulating acupuncture points |
US20110172746A1 (en) * | 2010-01-12 | 2011-07-14 | Roger Porter | High Level Laser Therapy Apparatus and Methods |
US8968376B2 (en) | 2010-05-28 | 2015-03-03 | Lockheed Martin Corporation | Nerve-penetrating apparatus and method for optical and/or electrical nerve stimulation of peripheral nerves |
US8864806B2 (en) | 2010-05-28 | 2014-10-21 | Lockheed Martin Corporation | Optical bundle apparatus and method for optical and/or electrical nerve stimulation of peripheral nerves |
US8792978B2 (en) | 2010-05-28 | 2014-07-29 | Lockheed Martin Corporation | Laser-based nerve stimulators for, E.G., hearing restoration in cochlear prostheses and method |
US8652187B2 (en) | 2010-05-28 | 2014-02-18 | Lockheed Martin Corporation | Cuff apparatus and method for optical and/or electrical nerve stimulation of peripheral nerves |
WO2011150430A3 (en) * | 2010-05-28 | 2012-02-23 | Lockheed Martin Corporation | Implantable infrared nerve stimulation devices for peripheral and cranial nerve interfaces |
US8894697B2 (en) | 2011-07-22 | 2014-11-25 | Lockheed Martin Corporation | Optical pulse-width modulation used in an optical-stimulation cochlear implant |
US8840654B2 (en) | 2011-07-22 | 2014-09-23 | Lockheed Martin Corporation | Cochlear implant using optical stimulation with encoded information designed to limit heating effects |
US8834545B2 (en) | 2011-07-22 | 2014-09-16 | Lockheed Martin Corporation | Optical-stimulation cochlear implant with electrode(s) at the apical end for electrical stimulation of apical spiral ganglion cells of the cochlea |
US8747447B2 (en) | 2011-07-22 | 2014-06-10 | Lockheed Martin Corporation | Cochlear implant and method enabling enhanced music perception |
US8709078B1 (en) | 2011-08-03 | 2014-04-29 | Lockheed Martin Corporation | Ocular implant with substantially constant retinal spacing for transmission of nerve-stimulation light |
US9696804B2 (en) | 2011-12-23 | 2017-07-04 | Pine Development Corporation | Systems and methods for eliciting cutaneous sensations by electromagnetic radiation |
US8574280B2 (en) | 2011-12-23 | 2013-11-05 | Pine Development Corporation | Systems and methods for eliciting cutaneous sensations by electromagnetic radiation |
US9257021B2 (en) | 2013-04-12 | 2016-02-09 | Pine Development Corporation | Systems and methods for optically induced cutaneous sensation |
US10295823B2 (en) | 2013-07-02 | 2019-05-21 | Pine Development Corporation | Systems and methods for eliciting cutaneous sensations using electromagnetic radiation |
CN105682738A (en) * | 2013-10-07 | 2016-06-15 | S·约翰逊 | A method and apparatus for controlling a laser probe |
EP3055023A4 (en) * | 2013-10-07 | 2017-05-17 | Susanne Johansson | An apparatus for controlling a laser probe |
US10610698B2 (en) | 2013-10-07 | 2020-04-07 | Susanne Johansson | Method and apparatus for controlling a laser probe |
US9449477B2 (en) | 2014-04-02 | 2016-09-20 | Pine Development Corporation | Applications of systems and methods for eliciting cutaneous sensations by electromagnetic radiation |
US10037661B2 (en) | 2014-04-02 | 2018-07-31 | Pine Development Corporation | Applications of systems and methods for eliciting cutaneous sensations by electromagnetic radiation |
CN103986444A (en) * | 2014-05-09 | 2014-08-13 | 健力普(北京)医疗科技有限公司 | Output control method and device for physical factors |
US20160066994A1 (en) * | 2014-09-09 | 2016-03-10 | Erchonia Corporation | Non-Invasive Method for Slimming a Human Body Using Two Wavelngths of Laser Energy Concurrently |
US9907975B1 (en) | 2014-11-19 | 2018-03-06 | Roger D. Porter | Therapeutic laser treatment and transdermal stimulation of stem cell differentiation |
US11517373B2 (en) * | 2016-12-27 | 2022-12-06 | Alma Lasers Ltd. | Switched lasers for dermal treatment |
CN109557092A (en) * | 2018-11-22 | 2019-04-02 | 中国人民解放军军事科学院国防科技创新研究院 | It is a kind of for enhancing the cranial nerve stimulating apparatus of big brain cognitive function |
Also Published As
Publication number | Publication date |
---|---|
CA2359807A1 (en) | 2000-10-05 |
KR20010090805A (en) | 2001-10-19 |
DE10084417T1 (en) | 2002-03-21 |
BR0007022A (en) | 2002-10-22 |
GB0111600D0 (en) | 2001-07-04 |
WO2000057804A9 (en) | 2001-10-18 |
GB2361646A (en) | 2001-10-31 |
MXPA01004154A (en) | 2002-06-04 |
HUP0301300A2 (en) | 2003-08-28 |
WO2000057804A1 (en) | 2000-10-05 |
EP1244391A1 (en) | 2002-10-02 |
AU3926600A (en) | 2000-10-16 |
US6267779B1 (en) | 2001-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6267779B1 (en) | Method and apparatus for therapeutic laser treatment | |
US8316860B1 (en) | Therapeutic laser treatment method | |
US6063108A (en) | Method and apparatus for localized low energy photon therapy (LEPT) | |
US7309348B2 (en) | Method for treatment of depression | |
US10379341B2 (en) | Multiple aperture hand-held laser therapy apparatus | |
US20070213792A1 (en) | Treatment Of Tissue Volume With Radiant Energy | |
US8251982B2 (en) | Laser apparatus for therapeutic applications | |
US20070219604A1 (en) | Treatment of tissue with radiant energy | |
US20130041309A1 (en) | Apparatus and method for performing radiation energy treatments | |
US20050065577A1 (en) | Low level laser tissue treatment | |
US20090132012A1 (en) | Method for pretreating patient before surgery | |
WO2001074230A2 (en) | Therapeutic laser system operating between 1000nm and 1300nm | |
Baxter | Low-intensity laser therapy | |
US7160287B1 (en) | Apparatus and method for performing radiation energy treatments | |
WO1999042178A1 (en) | Therapeutic cluster laser device | |
KR20100092077A (en) | Multi laser system for medical treatment | |
US10363430B2 (en) | Therapeutic laser treatment and transdermal stimulation of stem cell differentiation | |
KR200305857Y1 (en) | Low power living body treatment belt using a optical laser energy radiating | |
US11369802B2 (en) | Methods and systems for the therapeutic application of laser and cannabidiol to the skin | |
Baxter et al. | Laser/Photobiomodulation | |
US20240108407A1 (en) | Therapeutic laser system and method of use for activating the tissue stem cell niche for the treatment of medical conditions | |
WO2001032262A1 (en) | Miniature cluster laser therapy device | |
WO2024076585A1 (en) | Therapeutic laser system for activating the tissue stem cell niche for the treatment of medical conditions | |
KR200325740Y1 (en) | Dental Therapeutic apparatus using low level light irradiation equipments | |
AU2007227432A1 (en) | Treatment of tissue volume with radiant energy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |